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ABSTRACT 
 
The type II secretion system is used by many pathogenic and non-pathogenic bacteria for the 
extracellular secretion of enzymes and toxins.  Aeromonas hydrophila is a Gram-negative 
pathogen that secretes proteins via the type II secretion system.  
 
In the studies described here, a series of yeast two-hybrid assays was performed to identify 
protein-protein interactions in the type II secretion system of A. hydrophila. The periplasmic 
domains of ExeA and ExeB were assayed for interactions with the periplasmic domains of Exe 
A, B, C, D, K, L, M, and N.  Interactions were observed for both ExeA and ExeB with the 
secretin ExeD in one orientation.  In addition, a previously identified interaction between ExeC 
and ExeD was observed.  In order to further examine and map these interactions, a series of 
eight two-codon insertion mutations in the amino terminal domain of ExeD was screened 
against the periplasmic domains of ExeA and ExeB.  As a result, the interactions were verified 
and mapped to subdomains of the ExeD periplasmic domain.  To positively identify the region 
of ExeD involved in the interactions with ExeA, B, C and D,  deletion mutants of ExeD were 
constructed based on the two-codon insertion mutation mapping of  subdomains of the ExeD 
periplasmic domain, and yeast two-hybrid assays were carried out.  The results showed that a 
fragment of the periplasmic domain of ExeD, from amino acid residue 26 to 200 of ExeD, was 
involved in the interactions with ExeA, B and C.  As an independent assay for interactions 
between ExeAB and the secretin, His-tagged derivatives of the periplasmic domains of ExeA 
and ExeB were constructed and co-purification on Ni-NTA agarose columns was used to test 
for interactions with untagged ExeD.  These experiments confirmed the interaction between 
ExeA and ExeD, although there was background in the co-purification test.   
 
These results provide support for the hypothesis that the ExeAB complex functions to organize 
the assembly of the secretin through interactions between both peptidoglycan and the secretin 
that result in its multimerization into the peptidoglycan and outer membrane layers of the 
envelope.   
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1.0   INTRODUCTION 
The genus Aeromonas is a group of Gram-negative pathogens found in aqueous environments, 
which secrete a variety of extracellular protein toxins associated with pathogenicity and 
environmental adaptability.  Some members of the genus are highly lethal to aquatic mammals, 
fish, reptiles and cows, while others also cause disease in humans (Altwegg and Gless, 1989; 
Fivaz et al., 2001, Schoenhofen et al., 2005).  The Aeromonas infection is mainly associated 
with gastroenteritis, wound infections and systemic illness, but in immuno-compromised 
individuals infection may lead to lethal disease such as septicemia and meningitis (Fivaz et al., 
2001, Yu et al., 2007).  One member of this genus, Aeromonas hydrophila, can cause motile 
aeromonad septicemia in both fish and humans (Yu et al., 2007).  The major virulence 
mechanism of this species involves secretion of degradative enzymes and toxins into the 
external milieux (Schoenhofen et al., 2005).   Some of the virulence factors produced by A. 
hydrophila are surface structures, including pili, S-layers, polar flagella, and lateral flagella. 
Other extracellular virulence factors are secreted enzymes such as proteases, 
glycerophospholipid-cholesterol acyltransferase, hemolysins, aerolysin, lipases and 
metalloprotease (Yu et al., 2007).  Among these toxins, aerolysin is the best characterized 
(Fivaz et al., 2001).  These virulence factors are secreted into the media via different secretion 
pathways (Yu et al., 2007).  A. hydrophila secretes many of the protein toxins such as aerolysin 
via the type II secretion system (T2SS) (Ast et al., 2002).   
 
1.1  The type II protein secretion system 
The T2SS is part of the general secretory pathway (GSP) which includes 2 steps, passage across 
the inner and outer membranes (for recent reviews, see Sandkvist, 2001a,b; Filloux, 2004 and 
Johnson et al, 2006) (Fig. 1-1).  Table 1-1 shows T2SS nomenclature.  In the first step, 
exoproteins to be secreted are synthesized as precursors containing N-terminal cleavable signal 
peptides that target them to either the Sec or Tat machinery in the inner membrane (IM) 
(Voulhoux et al., 2001; de Keyzer et al., 2003; Palmer et al., 2005).  Following secretion into 
the periplasm, signal peptides are removed by the activity of leader peptidase, and the mature 
exoproteins are released into the periplasmic space, where they fold.  Up to now, several 
branches have been identified for the second step.  Among these branches, the T2SS, also 
known as the main terminal branch of the GSP, is used by many species of Gram- 
 2
 
 
 
 
FIG. 1-1.  Model of the type II secretion apparatus of A. hydrophila.   ExeA and ExeB form 
a complex in the IM and are required for the assembly and/or multimerization of the ExeD 
secretin in the outer membrane (OM).  The secretin consists of approximately 12-14 monomers 
which form a large oligomeric ring that functions as the translocation channel.  Proteins E, F, L 
and M form a complex which may be involved in the assembly of the pseudopilus. Both ExeA 
and ExeE are ATPases.  ExeC and ExeN connect the IM complex and ExeD, and may be 
involved in regulating the opening of the ExeD channel.  The pilus-like structure composed of 
protein G to K extends from the IM complex and may reversibly block the secretin channel or 
push the folded exoproteins out of the cell. The Sec machinery secretes the exoproteins from 
the cytoplasm to the periplasm. 
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TABLE 1-1.  T2SS nomenclature 
 
 
* The individual protein nomenclature for each bacterium is the same as that for the general 
secretion pathway (Gsp) protein unless listed in the table.  
Bacteria Protein name* Gsp Equivalent 
Aeromonas hydrophila Exe Gsp 
Erwinia chrysanthemi Out Gsp 
Klebsiella oxytoca Pul Gsp 
Pseudomonas aeruginosa 
(Pseudomonas Alcaligenes) 
XcpR, S, Y,Z 
XcpT, X 
XcpP, Q 
 
GspE, F, L, M 
GspG, K 
GspC, D 
Vibrio cholerae Eps Gsp 
Xanthomonas campestris XpsP GspC 
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negative bacteria, including A. hydrophila.  In this step, the fully folded exoproteins in the 
periplasm are recognized and translocated across the OM by components of the T2SS.  Since 
this apparatus apparently functions after the signal sequence-dependent transfer across the IM, 
it has been considered to form an extension of the Sec pathway and therefore to be part of the 
GSP.  The T2SS differs from most other membrane transport systems, in that its substrates 
consist of folded proteins (Sandkvist, 2001a).  Another distinguishing feature of the T2SS is 
that it has the ability to assemble a pilus-like structure, which is quite similar to the type IV 
pilin assembly system.  It is proposed to move like a piston to push the folded exoproteins out 
of the cell through the channel of the GspD secretin.  
 
The T2SS of A. hydrophila spans both inner and outer membranes and is comprised of at least 
14 proteins encoded by exe genes which are clustered into 2 operons, exeC-N and exeAB 
(Howard et al., 1993; Jahagirdar and Howard, 1994; Ast et al., 2002; Schoenhofen et al., 2005).  
The proteins encoded by these 2 operons form a secretion structure or machinery called the 
secreton.  The genes gspO and gspS occur in the T2SS of other species but are not found in that 
of A. hydrophila.  The T2SS is generally considered as consisting of three subassemblies: an IM 
platform, a periplasmic pseudopilus and an OM complex (Johnson, et al., 2006).  
 
1.2 The inner membrane complex 
Of the five integral cytoplasmic membrane proteins C, F, L, M and N, three of them including 
GspF, L and M, together with the cytoplasmic protein GspE, form an IM complex (Py et al., 
2001, Robert et al., 2005b).  The IM ternary complex appears to connect the secretion pore and 
the GspE protein component that is located in the cytoplasm.  In addition, it is presumably used 
as a platform for assembling other parts of the T2SS, especially the pseudopilus.   
 
GspL and GspM are two key components of the T2SS present in the IM.   Some studies have 
shown that EpsL and EpsM, homologs of GspL and GspM from Vibrio cholerae, are likely to 
form homodimers or homomultimers (Py et al., 1999; 2001; Johnson et al. 2007).  Yeast two-
hybrid analysis revealed that both the N-terminal cytoplasmic domains and the C-terminal 
periplasmic domains (peri) of EpsL and OutL, a homolog from Erwinia chrysanthemi, are 
involved in homodimer or homomultimer formation (Py et al., 1999, Douet et al., 2004, 
Abendorth et al., 2004a).  Furthermore, the peri-EpsM has been proved to be a part of the 
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interface between the IM platform and other components of the machinery (Abendorth et al., 
2004b).  This region of EpsM has further been revealed to be a binding site of an unknown 
ligand or part of a protein partner.  In addition, the specific regions of EpsM involved in 
oligomerization were identified and mapped by Johnson et al. (2007) showing that a 
periplasmic region, from residue 100 to 135, is responsible for homo-oligomer formation.  
Specifically, co-purification and co-immunoprecipitation of truncated EpsM mutants with 
Histidine-tagged EpsM showed that EpsM∆14, EpsM∆30 (C-terminal 14 and 30 amino acids 
were removed respectively) bound to EpsMHis6, while binding of EpsM∆66, EpsM∆82 (C-
terminal 66 and 82 amino acids were removed respectively) to EpsMHis6  was undetectable, 
suggesting that the C-terminus of EpsM (the last 30 residues) was not necessary for EpsM 
dimerization while the last 66 residues were required to stably interact with another EpsM 
molecule.  A yeast two-hybrid assay in both directions showed that the last 79 amino acids of 
the C-terminal region of OutM (OutM contains 162 amino acids), from residue 84 to 162, were 
responsible for OutM homodimer formation as well as for the OutLM interaction (Py et al., 
2001).  Based on these results, it can be hypothesized that a region near the TM in the peri-
ExeM or the whole periplasmic domain including the C-terminus contributes to the 
dimerization or oligomerization.  Although different regions were mapped for the self-
interaction, these results suggest that GspM may form dimers or larger oligomers through 
interactions involving the C-terminal end of the periplasmic domain.  It has also been 
demonstrated that GspL and GspM homologs in Pseudomonas aeruginosa, Klebsiella oxytoca, 
E. chrysanthemi and V. cholerae are capable of protecting each other from proteolytic 
degradation (Michel et al. 1998; Sandkvist et a., 1999; Py et al., 2001; Robert et al., 2002, 
2005b; Johnson et al., 2007).   In V. cholerae, EpsL and EpsM seem to interact with each other 
directly as no other Eps protein is needed for their assembly when they are expressed in 
Escherichia coli (Sandkvist et al., 1999).   Analysis of truncated EpsM mutants and co-
immunoprecipitation revealed that EpsM∆83 still appeared to interact with EpsL, though not as 
well as full-length EpsM, indicating that this fragment (residues 1-82) of EpsM is partially 
dispensable for EpsLM interaction.  These and other data on truncated EpsM mutants suggested 
that a region from residue 84 to 99 is required for a stable interaction with EpsL (Johnson et al., 
2007).   This result is in agreement with Py et al. (2001).  
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Another component of the IM complex, termed XpsN, a homolog of GspC of Xanthomonas 
campestris, could be co-immunoprecipitated with both XpsL and XpsM, suggesting that it 
might be involved in formation of the XpsL-XpsM complex in the T2SS (Lee et al., 2001).  
This result was further confirmed by metal-chelating chromatography and immunoblot analysis 
which revealed that both XpsL and XpsN co-eluted with His-tagged XpsM, and XpsL and 
XpsN co-immune precipitated with each other (Tsai et al, 2002).  Further purification by size-
exclusion chromatography followed by nickel affinity chromatography demonstrated that 
XpsL, XpsM and XpsN form a reversible ternary complex, that is, there is a dynamic 
relationship among the three components of the XpsLMN complex.  XpsN was not stably 
maintained in the complex and detached from it before dissociation of the other two 
components.  Conversely, XpsN preferentially associated with the XpsLM complex rather than 
to XpsM alone.  In addition, the dissociation rate of XpsL from the XpsLM complex was 
significantly greater than from XpsLMN complex, suggesting the presence of XpsN in the 
complex probably strengthens the association between XpsL and XpsM (Tsai et al, 2002), 
which corresponds to a previous study showing that XpsN was required for maintaining both 
XpsL and XpsM at normal steady state levels (Lee et al., 2001).   
 
Protein GspF, a polytopic integral cytoplasmic protein in secreton, is the least studied 
component of the IM complex.  The function of GspF and its interactions with other 
components of the ternary complex are not well known.  Yeast two-hybrid assays in one 
direction have revealed interactions of the N-terminal 172 residues of OutF with OutE, and with 
the cytoplasmic segment of OutL in E. chrysanthemi (Py et al., 2001).  Further co-
immunoprecipitation studies demonstrated that OutF formed a stable complex with OutE and 
OutL in vivo.  However, OutF was not necessary for the production of the OutE-OutL complex 
while OutL was required for the formation of the OutE-OutF complex.  Interactions between 
GspF and other components of the complex have also been demonstrated in P.aeruginosa.   
Reversible cross-linking and co-purification of XcpR (GspE), XcpS (GspF), XcpY (GspL) and 
XcpZ (GspM) suggested that these four components associated as a complex in the IM (Robert 
et al., 2005b).  Similarly, XcpS has been demonstrated to be stabilized by co-expression with 
XcpR and XcpY, indicating an interaction between these three components of the machinery 
(Arts et al., 2007).   Arts et al. (2007) also found that the cytoplasmic loop of XcpS was  
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involved in the stabilization by XcpR and XcpY, and the cytoplasmic domain of XcpS, from 
residue 240 to 376, seemed to be important for interaction with XcpRYZ.   In addition, two 
GspE and GspF homologs, BfpD and BfpE, which are required for biogenesis of the bundle-
forming pilus of enteropathogenic E. coli., have also recently been demonstrated to interact 
with each other (Crowther et al., 2004).  Further study by this group showed that the ATPase 
activity of BfpD was slightly stimulated by a fragment of the N-terminal cytoplasmic domain of 
BfpE (Crowther et al., 2005).  It can be concluded that the cytoplasmic proteins E, F, L, M and 
N form an IM complex via reversible association.  
 
1.3 GspE, the putative ATPase 
GspE belongs to a large family of  TypeII/TypeIV secretion nucleoside triphosphatases 
(NTPases), which are proposed to couple NTP hydrolysis to bacterial protein secretion (Planet 
et al., 2001).  GspE as well as other members of the NTPase family contain several conserved 
motifs including Walker A and B boxes, a histidine box and an aspartate box (Robin et al., 
2003).  It has been demonstrated that purified EpsE from V. cholerae is an Mg2+-dependent 
ATPase, and the 3D structure of an N-terminal deletion derivative was determined (Robien 
et al., 2003; Camberg and Sandkvist, 2005).  It was also shown that EpsE displays cooperative 
ATPase activity as the specific activity of EpsE was influenced by its concentration (conc.), and 
this result together with previous studies on OutE (Py et al., 1999), indicated that type II 
secretion ATPases can assemble into oligomers (Camberg and Sandkvist, 2005).  Gel filtration 
showed that purified EpsE contained a small fraction of hexamers with increased specific 
activity and the crystal structure of the N-terminal deletion derivative (∆90EpsE) revealed a 
helical filament with six fold symmetry (Robien et al., 2003).   In addition, several structural 
homologues of EpsE such as HP0525, a type IV secretion NTPase of Helicobacter pylori, and 
PilT, the type IV pilus retraction ATPase, have been shown to be hexameric ATPases (Yeo et 
al., 2000; Forest et al., 2004).  These findings suggest that functional GspE may form a 
hexameric ring associated with the IM that is involved in pseudopilus assembly (Robien et al., 
2003).  EpsE of V. cholerae and OutE of E. chrysanthemi were both demonstrated to associate 
with the cytoplasmic membrane through interactions with the N-terminal cytoplasmic domain 
of EpsL and OutL (Sandkvist et al, 1995, 1999; Py et al, 1999).  Yeast two-hybrid assays in 
both directions in E. chrysanthem also suggested that the N-terminal cytoplasmic domain of 
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OutL was involved in OutE-OutL interaction (Py et al, 1999).  These results have been 
confirmed  by the X-ray crystal structure of a hetero-tetrameric complex formed between 
subdomains of EpsL and EpsE showing that two regions, both located in the cytoplasmic 
domain of EpsL, are involved in interactions with the N-terminal cytoplasmic region of EpsE 
(Sandkvist et al, 2000; Abendroth et al. 2005).   
Although a recent study demonstrated that X. campestris XpsE oligomerization was triggered 
by ATP binding, which led to its association with the N-terminal domain of XpsL (Shiue et al., 
2006), the HP0525 ATPase of H. pylori oligomerized independent of ATP (Savvides et al., 
2003), and yeast two-hybrid assay demonstrated that mutations of the Walker A box in OutE 
did not influence its interaction with OutL (Py et al., 1999).  Shiue et al. (2006) also showed 
that XpsE–XpsL association precedes ATP hydrolysis and stimulates this activity.  The weak 
ATPase was stimulated two-fold by a fusion protein containing the cytoplasmic domain of 
XpsL.  Shiue et al. (2007) further identified a key residue, R286, of the ATPase XpsE which 
facilitates a critical role in coupling ATP hydrolysis to protein translocation.  The result was 
obtained by site-directed mutation of XpsE.  Although mutation of R286 to alanine increased 
the rate of XpsE ATP hydrolysis five times compared to that of the wild-type (WT) XpsE, the 
mutant lost ATP-binding affinity and ability to oligomerize.  As a result, the mutant was not 
able to associate with the IM via XpsLN, and ATP hydrolysis by XpsE was uncoupled from 
protein secretion.  Therefore, the mutant became non-functional in protein secretion.   
Conversely, Camberg et al. (2007) found that ATP-binding was not a requirement for complex 
formation of EpsE with EpsL.  EpsE of V. cholerae was shown to be a hexamer with weak 
ATPase activity (Camberg and Sandkvist, 2005).  The ATP hydrolysis assay demonstrated that 
acid phospholipids, including phosphatidylglycerol and cardiolipin, stimulated ATPase activity 
of EpsE by 30 fold and 130 fold respectively; however, the stimulation was observed for the 
EpsE/EpsL (1-253) complex but not for EpsE alone.  By altering the order of addition of ATP 
and cardiolipin in the ATP hydrolysis assay, they revealed that direct binding of the EpsE/EpsL 
(1-253) complex to acid phospholipids was required for the activation.  These studies thus 
suggested that the stimulation of ATPase activity requires a properly formed conformation of 
EpsE, which results from association of EpsE and the cytoplasmic domain of EpsL and is 
responsive to the presence of acid phospholipids.  In addition, EpsE and EpsL (1-253) could be 
cross-linked to form a larger molecular species which could be recognized by both anti-EpsE 
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and anti EpsL antibodies, and EpsL (1-253) substitution mutants showed a reduced rate of ATP 
hydrolysis compared to the non-mutated EpsE/EpsL (1-253), suggesting that EpsL (1-253) 
might be involved in fine tuning the interaction of EpsE with phospholipids in the IM and thus 
regulating its oligomerization and promoting ATPase activity (Camberg et al. 2007).   
1.4 The pseudopilins  
The pseudopilins of T2SS encoded by gspG-K have been proposed to extend from the IM 
complex and form a pilus structure in the pore of the OM complex spanning the cell envelope, 
acting as a piston and/or plug to translocate substrates and exoproteins through the OM secretin 
pore (Hobbs and Mattick, 1993; Nunn, 1999; Sauvonnet et al. 2000; Ast et al., 2002; Peabody 
et al., 2003).  The pseudopilus may extend from the GspEFLM complex in the IM complex, 
which may be involved in its assembly.  The T2SS pseudopilins are similar to the pilins that are 
assembled into the type IVa pilus (Filloux et al., 1998; Mattick et al., 1995; Sandkvist 2001).  
The recently published crystal structure of a truncated form of PulG from K. oxytoca revealed 
that PulG and the type IV pilins displayed a similar structure made up of an N-terminal 
hydrophobic α-helix followed by four β-strands arranged in a globular domain (K¨ohler et al., 
2004).  Among the T2SS pseudopilins, GspG, termed ‘major’ pseudopilin, is the most 
abundant, whereas GspH, GspI, GspJ and GspK are low abundance ‘minor’ pseudopilins, 
which may contribute to initiation, stabilization, regulation, or capping of the periplasmic piston 
filaments to achieve secretion (Nunn and Cleavage, 1993; Sauvonnet et al., 2000; Forest, 
2008).  Cross-linking and immunoblot analysis showed that XpsG interacts directly with 
secretin XpsD and XpsN in X. campestris pv.Campestris, and the association of XpsG with 
XpsD was strongly dependent on the expression of XpsN (Lee et al., 2005), suggesting that 
GspG and the secretin GspD are in contact at certain stages during the secretion process, and 
this contact may be regulated by GspC, indicating that GspC may play a direct role during 
pseudopilus assembly or activity as well.  GspK has been shown to control the pseudopilus 
assembly and may interact directly with GspG (Durand et al. 2005).  The same study further 
confirmed that only XcpT (GspG) of P. aeruginosa, the major pseudopilin, could be assembled 
in a multifibrillar structure termed the pseudopilus, while none of the four minor pseudopilins 
had this characteristic, suggesting that the assembly into a pseudopilus is a unique property of 
GspG.  Furthermore, XcpX (GspK) was shown to destabilize XcpT (GspG) when 
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overexpressed, and this phenomenon together with cross-linking experiments revealed that 
GspK interacts with GspG.   In addition, the study revealed that the pseudopilin XcpX is 
important in controlling the pseudopilus elongation process, and this control was probably 
exerted via a direct interaction between XcpX and XcpT.  These results suggest that GspK may 
be involved in the interactions with other pseudopilins during pseudopilus assembly and/or 
functioning.  A recent study showed that GspK forms a ternary complex with GspI and GspJ in 
E. coli. (Korotkov and Hol., 2008).  The X-ray crystal structure of the GspK–GspI–GspJ 
heterotrimer suggested that this complex might be located at the tip of the pseudopilus, and an 
inserted α-helical domain of GspK might form the tip of the piston with GspK and GspJ 
positioned in such a way that additional pseudopilin subunits extend below but not above the tip 
of GspK.  This result is in agreement with the previous study showing that XcpX (GspK) 
controls the length of the pseudopilus in P. aeruginosa (Durand, et al. 2005).  The GspK–GspI–
GspJ tip probably interacts at least transiently with T2SS components in the OM, in particular 
with the secretin GspD (Korotkov and Hol, 2008).   
1.5. GspC and GspN, the connecting components 
GspC is a bitopic IM protein which is proposed to connect the IM platform and OM 
components of the T2SS (Bleves et al., 1999; Possot et al., 2000; Gérard-Vincent, et al., 2002).  
GspC consists of a short N-terminal cytoplasmic sequence, a single TMS (transmembrane 
segment), and a large C-terminal hydrophilic periplasmic region (Bleves et al., 1996; Thomas 
et al., 1997; Gérard-Vincent, et al., 2002; Robert et al., 2005a; Korotkov et al., 2006).  
 The majority of the GspC homologs contain a PDZ domain near their C termini (Pallen and 
Ponting, 1997).  However, the PDZ domain is absent in some GspC family members and 
replaced by a coiled coil domain (Gérard-Vincent, et al., 2002; Peabody et al., 2003).  Both 
PDZ domains and coiled coil domains are known to be involved in protein-protein interactions 
(Bleves et al., 1999; Bouley et al., 2001; Gérard-Vincent, et al., 2002; van Ham & Hendriks, 
2003). These two domains may also be responsible for multimerization.  Analysis of XcpP 
(GspC)-OutC chimeras composed of the XcpP coiled coil exchanged for the PDZ domain of 
OutC revealed that these two structurally different regions could be exchanged and the resulting 
hybrid could be integrated into a functional secreton, suggesting that both the coiled coil 
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domain of XcpP and the PDZ domain of OutC could be involved in the formation of homo-
multimeric complexes but not required for interaction with other proteins (DaeGérard-Vincent 
et al., 2002).  However, a recent study showed that the absence of the PDZ domain does not 
affect OutC self-interaction (Login and Shevchik, 2006).  Thus the PDZ region or the coiled 
coil structure of GspC homologs may be either involved in homotypic interactions in the 
formation of homomultimers or interaction with other proteins.  Other regions of GspC may 
also contribute to homo-oligomerization.  Login and Shevchik (2006) suggested that the TM 
domain drives the self-association of OutC that is essential for the formation of a functional 
secretion system, whereas the periplasmic region is dispensable for homodimerization, 
corresponding to the previous studies by Robert et al. (2005a) and Korotkov et al (2006).   
 
In addition to homodimerization and protein-protein interaction, the PDZ domain or a coiled 
coil domain may also be involved in the recognition of secreted proteins and confer secretion 
specificity to a subgroup of secreted proteins.  Bouley et al. (2001) found that OutC of E. 
chrysanthemi containing partial or complete deletions of the PDZ motif became selectively 
functional in that the secretion of three exoproteins was unaffected while the secretion of the 
majority of pectate lyase was completely abolished.  Conversely, by domain swapping between 
XcpP of P. aeruginosa and OutC of E. Chrysanthemi, Gérard-Vincent et al. (2002) suggested 
that 35 residues in the TM/HR domain [a fragment from residue 50 to 85 between the TM and 
high homology domain (HR)] of XcpP might contribute species specificity since this region 
was non-exchangeable and was involved in the stability of the XcpYZ secreton subcomplex and 
the functionality of the XcpP machinery.  However, this hypothesis was later questioned by the 
study of Robert et al. (2005a).   In this study, the specificity function of the TM/HR domain 
was further analyzed by domain swapping of XcpP of P. aeruginosa with XcpP of 
Pseudomonas Alcaligenes.  In contrast to the T2SS of E. chrysanthemi, the T2SS of P. 
alcaligenes promotes heterologous protein secretion in P. aeruginosa.  The results showed that 
the TM/HR domain of P. aeruginosa XcpP could be substituted by the corresponding domain 
of P. alcaligenes XcpP without affecting the functionality of the Xcp system, indicating that the 
TM/HR domain might not contribute to species specificity.   
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GspC has been suggested to interact with the OM protein GspD since homo-trimer formation, 
stability and proper function of GspC required GspD (Shevchik et al., 1997; Bleves et al., 1999; 
Possot et al., 1999; Lee et al., 2000).   However, previous results have shown discrepancies 
concerning the region of GspC involved in the interaction with GspD.  As described above, the 
PDZ domain or a coiled coil domain of GspC may be involved in protein-protein interactions.  
An earlier study suggested that the N-terminal TM and the coiled coil structure at the C 
terminus of XcpP (179-212) might be responsible for the protein-protein interaction during 
assembly of the secretory machinery (Bleves et al., 1999).  Analysis of truncated XcpP mutants 
showed that XcpP∆19, a mutant lacking the coiled coil structure, failed to complement an xcpP 
deletion mutant, while XcpP∆M which lacked the XcpP C-terminus including the coiled coil 
structure and the 22 C-terminal residues of the wild type (WT) protein not only complemented 
the mutation but also resulted in an increased level of secretion.  These results suggested that 
the coiled coil structure at the C terminus of XcpP play a key role for XcpP function.  
Moreover, the contradictory results of the two mutants led to a hypothesis that the N-terminal 
domain of XcpP of P. aeruginosa may negatively control the opening of the XcpQ (GspD) 
secretin channel directly or via interaction with another Xcp protein, leading to efficient 
secretion.  Although XcpP∆19 also contained the N-terminal domain, the 22 C-terminal 
residues which were absent in XcpP∆M  might be involved in negatively controlling the 
secretion process via maintaining the XcpQ pores in a closed conformation, resulting in the 
noncomplementation of the Xcp deletion mutant strain by the XcpP∆19 variant.  In contrast to 
this result, recent studies suggested that the C-terminal peri-GspC is involved in the interaction 
with GspD (Robert et al., 2005a; Korotkov et al., 2006), while the PDZ domain or coiled-coil 
structure of GspC does not interact with GspD (Korotkov et al., 2006).  Robert et al. (2005a) 
constructed hybrid proteins by domain swapping with the corresponding regions of P. 
alcaligenes XcpP and E. chrysanthemi OutC, and then tested the stability of the hybrids in the 
presence or absence of XcpQ.  The results suggested that it is the C-terminal domain of XcpP 
that might be involved in the interaction with XcpQ.  In addition, other experiments with XcpP 
also excluded the possibility that the interaction was in a species-specific manner.  Although the 
XcpP-XcpQ interaction promoted via the C-terminal domain of XcpP was not essential for the 
secretion process, the study suggested that this region might be involved in a fine tuning control 
of the channel opening of the secreton, corresponding to the previous study by Bleves et al. 
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(1999).  The exact region in the C-terminus of GspC that interacts with GspD was further 
mapped by Korotkov et al. (2006) with co-purification showing that the periplasmic HR 
domain of EpsC of V. cholerae (residue 75 to 177) interacts with EpsD.  Based on these results, 
it has been hypothesized that different exoproteins secreted by the T2SS of a given species 
possess a variable number of targeting signals which are recognized by different regions of 
GspC and GspD.  In addition, this complex mechanism probably involves a structural 
recognition signal (Robert et al., 2005a). 
 
Genetic and biochemical studies suggested that GspC interacts, at least transiently, with the IM 
proteins GspL and GspM and stabilizes the GspLM subcomplex (Possot et al., 1999, 2000; 
Gérard-Vincent et al., 2002; Robert et al., 2002, 2005b; Lee et al., 2004).   
Gérard-Vincent et al. (2002) suggested the existence of an XcpP–XcpY–XcpZ (GspCLM) 
subcomplex in P. aeruginosa.  The evidence showed that XcpZ45, an XcpZ (GspM) derivative 
that lost its function in conferring XcpY (GspL) stability when co-produced in E. coli, could 
stabilize XcpY in the presence of XcpP (GspC).  The study showed that introducing the genes 
encoding xcpZ45 and xcpY into E. coli resulted in a low level of XcpY, however, this defect 
was compensated by the introduction of the WT xcpP gene, but not by introduction of the outC 
gene.  Therefore, to determine which domains of XcpP might be involved in this effect, xcpP–
outC chimeras carrying the TM/HR region of OutC were expressed in E. coli containing 
xcpZ45 and xcpY.  The chimeras were not able to restore the stabilizing activity of XcpZ45 on 
XcpY, indicating that the TM/HR domain of XcpP might be involved in the stability of the 
XcpP–XcpY–XcpZ subcomplex.  Similarly, TM domain was also supposed to contribute to this 
function.  In contrast to the interaction between GspC and the IM complex, the interaction 
between GspC and GspD described above suggests that those regions of GspC are essential for 
linking the IM complex to the OM secretin.  In addition, subcellular fractionation has revealed 
that PulC of K. oxytoca partly fractionates in the OM (Bleves et al., 1999; Possot et al., 1999).  
For example, the subcellular fractionation done by Possot et al. (1999) showed that the N-
terminal hydrophobic domain of PulC of K. oxytoca inserted into IM while the C-terminal 
region of PulC (residue 245 to 285) was involved in the regulation of the association with the 
OM.  The study also used cross-linking of proteins in whole cells and found formation of a 110 
kDa band which reacted with PulC-specific serum and whose detection required the presence of 
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PulD.  However, the band was not a PulC-PulD hetero-dimer (31 kDa + 68 kDa), because it did 
not react with antibodies specific for PulD, indicating that the 110 kDa band could be a homo-
PulC trimer whose formation required PulD.  In addition, PulC was not stabilized by PulD since 
no difference was observed in the yields of PulC in strains with or without PulD.  Based on the 
results of GspC-D interactions, GspC-GspLM interactions and the fractionation of GspC into 
both the IM and OM, it can be hypothesized that GspC connects the IM complex GspEFLM 
and the OM complex GspDS by interacting with GspLM of the IM complex and the OM 
protein GspD.   
 
In addition to GspC, GspN is also a bitopic IM protein which has been suggested to connect the 
IM and OM.  It has been identified only in some T2SS, such as A. hydrophila, K. oxytoca, 
Erwinia carotovora, X. campestris and Pseudomonas putida, while it is absent in many other 
T2SS (Filloux, 2004).  In X. campestris, XpsN has been considered as a homolog of GspC for 
the following reasons.  First, there is no GspC component in the secretion apparatus, and the 
function of XpsN is quite similar to that of GspC; second, the membrane topology of xpsN is 
similar to that of xpsP (gspC); third, XpsN, as well as GspC, contains a coiled coil domain in its 
C-terminal section.  Immunoblot analysis and nickel-nitrilotriacetic acid (Ni-NTA) affinity 
chromatography revealed that XpsN formed a stable complex with the C-terminal region of 
XpsD (residue 650-759), confirming the interaction between GspC and GspD (Lee et al., 2000).   
In addition to the interaction with XpsD, others studies also found that XpsN was involved in 
the formation of the XpsLM subcomplex (Lee et al. 2001; Tsai et al., 2002).  Furthermore, 
residue 47 to 97 have been identified to play an important role in interacting with XpsL and 
XpsM, and the N-terminal 46 residues were shown to be important for maintaining the two IM 
proteins at normal levels as well as maintaining a stable association with the subcomplex (Lee 
et al., 2004).  Since most T2SS contain both GspC and GspN, it is not clear what the 
relationship is between the two proteins or whether their functions overlap.   
 
1.6  The outer membrane complex 
GspD belongs to a large family of homologous proteins generically designated secretin.  It is an 
OM protein required for the T2SS, type IV pilus biogenesis, type III protein secretion, 
filamentous bacteriophage extrusion and uptake of DNA (Genin and Boucher, 1994).  
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Therefore, secretins constitute a very important group of macromolecule transporters in the OM 
of Gram-negative bacteria.  Some of the GspD homologues have been purified and 
characterized by electron microscopy.  They form highly stable [heat and detergent sodium 
dodecyl sulphate (SDS)-resistant] large oligomeric rings in the OM, consisting of 
approximately 12-14 monomers with a central cavity that ranges from 50 to 100 Å in diameter 
that are occluded with a centrally located plug (Bitter et al., 1998; Nouwen et al., 1999, 2000; 
Chami et al., 2005).  However, the regulation of the opening and closing of the central cavity 
and the components involved in this activity is not well studied.  A recent study on the very C-
terminal region of XcpP (GspC) of P. aeruginosa showed that either deletion or modification of 
this region results in increased levels of secreted proteins released to the extracellular 
environment, therefore it can be hypothesized that this region may contribute to regulation of  
the gating of the pore (Robert et al., 2005a).  In addition, the exoprotein pullulanase of K. 
oxytoca has been suggested to be a regulator of the channel (Chami et al., 2005).  In this study, 
the PulD polypeptide was found to be comprised of an N domain, which formed the walls of 
one of the chambers, and a trypsin-resistant C domain, which contributed to the outer chamber, 
the central disc, and the plug.  The pullulanase may bind to the inner chamber which is 
proposed to constitute a docking site for the secreted proteins.  As a result, the outer chamber 
allows displacement of the plug to open the channel and permit the exoprotein to be secreted.  
Sequence comparisons have shown that the C-terminal domain is highly conserved in all 
members of the secretin family whereas the N-terminal domain is variable and only shows 
conservation within the different subfamilies (Genin and Boucher, 1994; Peabody et al., 2003).  
Limited proteolysis and protease protection experiments have shown that the conserved C-
termini of XcpQ (GspD) and PilQ of P. aeruginosa and PulD of k. oxytoca are protease-
resistant and remain a multimer after proteolysis.  This domain contains several putative 
amphipathic transmembrane β-strands, suggesting that the C-terminal domain of GspD may be 
embedded in the OM and is likely to form the actual channel, while the N-terminal domain is 
probably exposed to the periplasmic space, where it facilitates interactions with other 
components of the secretion apparatus (Bitter et al., 1998, Brok et al., 1999; Nouwen et al., 
2000).  It has also been suggested that the C-terminal domain is responsible for OM insertion 
and multimerization, while the N-terminus may interact with exoproteins in the periplasmic 
space in addition to other T2SS components (Shevchik et al., 1997; Bouley et al., 2001).  
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Deletion mutations, gel filtration and ion exchange chromatography analysis revealed that two 
fragments, from residue 429 to 544 and from residue 544 to 759 in the C-terminal domain of 
XpsD were required for OM insertion and multimerization.  This is because the WT XpsD 
protein could co-fractionate with XpsD (Δ29–428) or XpsD (Δ448–650) but not with XpsD 
(Δ74–303) or XpsD (Δ553–759) (Chen et al., 1996).  Although the fragments from residue 429-
544 and from residue 544-759 were partially contained in the XpsD (Δ448–650) protein, the 
mutant could neither form functional multimers by itself nor function in protein secretion.  In 
addition, the XpsD (Δ74–303) mutant contained these two fragments, however, it only formed 
non-functional multimers.  Another study showed that the N-terminus may interact with 
exoproteins in the periplasmic space in addition to other T2SS components (Shevchik et al., 
1997).  In vivo co-immunoprecipitation and co-sedimentation in sucrose density gradients 
showed that PelB, a secreted protein, co-migrated with the OM fraction in the presence of 
OutD, and co- precipitation of the two proteins revealed that OutD bound to streptavidin–
agarose in the presence of biotinylated PelB, suggesting that OutD interacts with PelB.  The N-
terminal region of OutD was required for the interaction with secreted proteins since a 50 
amino acid N-terminal deletion of OutD prevented its interaction with PelB.  The study also 
suggested that the N-terminal domain may gate the pore it is forming, and a modification 
of the structure of the channel was provoked by the interaction of the secreted proteins with 
OutD.  
 
In addition to the two functions of the N and C termini described above, Guilvout et al. (1999) 
also suggested that both the N-terminal and C-terminal region of PulD were required for 
multimerization.  Linker and deletion mutagenesis and gene fusions showed that the SDS-
resistant multimer formation of the C domain strongly depended on N domain production in 
trans.  In detail, insertion of 24 amino acids near or within the C-terminus abolished SDS-
resistant multier formation, whereas insertions elsewhere had less effect on multimerization.  
However, the C-terminal domain did not form multimers unless part of the N-terminal region 
was produced in trans.  Furthermore, the function of all of a group of insertion mutants of PulD 
was abolished, except one close to the C terminus of the protein.  In addition, the highly 
unstable N domain did not form SDS-resistant multimers even in the presence of the C domain 
produced in trans.  All these results suggested that the C-terminal domain is responsible for 
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multimer stability while the N domain contributes to multimer formation.  Similar to the study 
of Guilvout et al. (1999), limited proteolysis and analysis of a three-dimensional model of the 
homomultimeric complex PulD identified a lower proportion of transmembrane β-structure of 
the trypsin resistant C domain than classical OM proteins, suggesting that only a small part of it 
is embedded within the OM (Chami et al., 2005).  This result leads to a hypothesis that the 
centrally plugged channel formed by C domain penetrates both the peptidoglycan (PG) on the 
periplasmic side and the lipopolysaccharide (LPS) and capsule layers on the cell surface.  
Therefore, the basic core structure formed by the C-domain is not only required for stable 
mutimerization but also interaction with other envelope components such as LPS and PG.   
 
Species specificity is another function in which GspD is involved.  T2SS is highly specific and 
secretion of heterologous exoproteins is rarely observed despite strong conservation of this 
secretion pathway, even when they are expressed in closely related species, such as E. 
chrysanthemi and E. carotovora (Lindeberg et al., 1996), or P. aeruginosa and P. alcaligenes 
(de Groot et al., 2001).  In Erwinia, GspE-N can be exchanged between the two different 
species, but GspC and GspD are not exchangeable, and these proteins have thus been suggested 
to be the gatekeepers of the T2SS (Lindeberg et al., 1996) and to confer specificity for substrate 
recognition (Bouley et al., 2001).  Bouley et al. (2001) identified an N-terminal region of OutD 
important for secretion specificity by using complementation tests with chimeric constructs 
between OutDEca and OutDEch.  The results showed that the N-terminal region of OutD, 
including a linker segment between the N and C-terminal domains, is involved in secretion 
specificity in E. chrysanthemi.  However, these results seem to be contradictory to a study by 
Guilvout et al. (1999) which indicated that substrate recognition did not require the N domain 
of PulD.  This conclusion was based on complementation tests showing that chimeric 
constructs containing the N-terminal region of OutDEch and the C-terminal part of the secretin 
PulD were able to complement a ΔpulD mutation.  A recent study demonstrated that both C 
terminal and N-terminal domains of XcpQ of P. alcaligenes are involved in species specificity 
(Bitter et al., 2007).  Although XcpP and XcpQ of P. alcaligenes could not substitute for their 
respective P. aeruginosa counterparts, these bacteria could secrete exoproteins of each other, 
indicating that species-specific recognition of exoproteins was not the reason for these 
complementation failures (de Groot et al., 2001).  Furthermore, complementation occurred 
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when P. alcaligenes xcpP and xcpQ were expressed simultaneously in a P. aeruginosa xcpPQ 
deletion mutant on agar plates.  Therefore, to map the region in the C-terminal domain (amino 
acid residue 326 to 606) of XcpQ of P. alcaligenes contributing to species specificity, Bitter et 
al. (2007) constructed chimeras between xcpQalc and xcpQaer secretins since expression of 
xcpQalc in an xcpQ mutant of P. aeruginosa does not restore protein secretion via the T2SS.  
Specifically, chimeras contained variable N-terminal fragments of XcpQaer and the 
complementing C-terminal domain of XcpQalc.  The analysis showed that the elastase secretion 
defect of a chromosomal xcpQ mutant strain could be complemented efficiently with the F478 
hybrid containing an N-terminal pre-XcpQaer fragment consisting of 478 or more amino acid 
residues, whereas no complementation occurred in the fusions with an N-terminal pre-XcpQaer 
fragment consisting of less than 331 amino acid residues.  Moreover, secretion in the P. 
aeruginosa xcpQ mutant could be completely restored by a hybrid containing the same C-
terminal segment of XcpQalc that was present in hybrid F497 and another XcpQalc segment 
extending from residue 68 up to residue 344.  Thus it was concluded that the region in the C-
terminus of XcpQaer between amino acid residues 344 and 478 appears to contain an important 
determinant for species-specific function in P. aeruginosa. This study also suggested that the N-
terminal 63 amino acid residues may contribute to this function.  In addition to investigating the 
species-specific function of XcpQaer, the study also revealed that LPS had a role in the 
functioning of secretins.  First, the C-terminal domain involved in the species specificity was 
probably in close contact with LPS as this region is located in the OM.  Second, mutations 
affecting LPS structure had a negative effect on the endogenous secretin of P. aeruginosa, but a 
positive effect on the XcpQalc secretin, indicating that there was a direct interaction between 
LPS and XcpQ.  Third, both P. alcaligenes XcpQ and inactive hybrids functioned properly in 
P. aeruginosa under high cons. of divalent cations known to affect the structure of LPS.  
Therefore, changes in LPS structure influence the functioning of the protein transport channel 
in the secretin.  
 
1.7  GspS, the pilotin for GspD 
A number of studies have focused on how secretin inserts into the OM and assembles into an 
oligomeric ring.  It has been found that some secretins contain an S domain at the C-terminal 
region that is the binding site for an OM-associated lipoprotein chaperone, GspS (termed 
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pilotin) (Daefler et al, 1997), which is specifically required to protect secretins from proteolysis 
and to direct its insertion to the OM (Hardie et al, 1996a, b; Daefler and Russel, 1998; Shevchik 
and Condemine, 1998).   In the absence of PulS, PulD assembles in the IM and induces the 
phage shock response, resulting in the production of great amounts of PspA, a 26 kDa 
peripheral membrane protein (Hardie et al, 1996a, b; Guilvout et al., 2006).   In addition, 
neither the PulS signal sequence, which protected PulD from cleavage, nor a periplasmic MalE-
PulS hybrid protein facilitated the proper localization of PulD to the OM, suggesting that PulD 
and PulS interact with each other directly (Hardie et al., 1996b).  A chimeric protein composed 
of bacteriophage f1 pIV and the C-terminal domain of PulD required properly localized PulS to 
support phage assembly, therefore the region of PulD required for protection by PulS was 
examined by analysis of the stability of a series of chimeric proteins composed of variable C-
terminal segments of PulD fused to variable N-terminal segments of fl pIV (Daefler et al, 
1997).  The result showed that a hybrid lacking the C-terminal 65 amino acids of PulD could 
not be stabilized by PulS, indicating that this fragment was the PulS-binding site.  Similar 
results were found in E. chrysanthemi by ligand-blotting experiments which showed that OutS 
did not bind to OutD lacking the C-terminal 62 and 328 amino acids, indicating that at least the 
62 C-terminal amino acids of OutD are required for interaction with OutS (Shevchik and 
Condemine, 1998).  Furthermore, the 62 C-terminal amino acids of OutD might only be 
involved in the stabilization of OutD while not contributing to its insertion to the OM in the 
presence of OutS because a hybrid composed of this fragment and the secreted pectate lyase 
PelD was only stabilized by OutS without OM insertion.  The insertion of OutD in the OM 
might require other proteins.  Guilvout et al.(2006) revealed that a PulD-CS (C and S domain) 
fragment was targeted to the OM via association with PulS. The same experiment further 
suggested that the regions of PulD which were responsible for its special requirements for 
extraction from the OM were completely determined by the C (and S) domains.  This is because 
the PulS-bound PulD-CS in cell envelopes could only be extracted under conditions that also 
extracted PulD.  The study also purified PulD-CShis from E. coli together with PulS by affinity 
chromotography, which was then treated with phenol. Dodecyl sulphate-polyacrylamide gel 
electorphoresis (SDS-PAGE) and Coomassie blue staining showed that the multimers 
disappeared after phenol treatment and generated a band which migrated faster than monomeric 
PulDhis and reacted with PulD antibodies, suggesting that PulD-CS formed PulD-like 
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multimers in the OM.  However, PulS was not required for the formation of PulD multimers as 
PulD-CShis (a His tag inserted in the S-domain) formed multimers without PulS.  To determine 
the role of PulS, the envelopes from a protease-deficient strain were centrifuged in floatation 
sucrose gradients, and immunoblotting of the resulting fractions after phenol-treatment revealed 
that PulD-CS and full-length PulD monomers predominantly inserted in the IM without PulS, 
suggesting that PulS prevents mislocalization of PulD-CS and PulD to the IM (Guilvout et al., 
2006).  However, the T2SS of some other bacteria do not have GspS pilotin; instead, secretin 
assembly requires other ancillary factors, such as ExeA and ExeB proteins in A. hydrophila 
(Ast et al, 2002) and the ExeB homolog OutB in E. chrysanthemi (Condemine and Shevchik, 
2000).  In addition, it was suggested that YaeT (the general OM insertion factor Omp85) in 
Neisseria meningitides may be involved in secretin assembly since it is required for porin 
assembly (Voulhoux et al, 2003; Bayan et al, 2006).  However, Guilvout et al. (2006) 
suggested that multimerization and OM association of PulD could be YaeT-independent since 
PulD formed dodecamers in the IM without PulS, and thus do not contact the OM protein 
YaeT. This suggestion is confirmed by a recent study showing that PulD was resistant to 
extraction by either the detergent Sarkosyl and or by urea, and susceptible to trypsin digestion 
(Collin et al.  2007). 
 
1.8  Isolation of exe genes of A. hydrophila 
To study T2SS of A. hydrophila, a group of exe genes belonging to two operons have been 
isolated and analyzed in our lab.  In previous studies of aerolysin secretion, Jiang and Howard 
(1991) isolated a number of Tn5-751 insertion mutants of A. hydrophila strain Ah65 using 
transposon mutagenesis, and analysis showed that these mutants were unable to secrete 
extracellular proteins.  Furthermore, two of these mutants, including C5.84 and L1.97 were 
pleiotropic, essentially devoid of any of the major extracellular proteins normally secreted by 
the WT.  However, immunoblot and cell fraction experiments revealed that these extracellular 
proteins were synthesized and accumulated in the periplasm, indicating that the genes 
inactivated by the transposon are important only for OM translocation of the proteins.  In 
addition, the WT fragment corresponding to the L1.97 mutation could partially restore the 
mutation in C5.84, suggesting that these two genes or their products may interact with each 
other during OM translocation.  
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To identify mutant genes, a KpnI 4.1 kb fragment which complemented the L1.97 mutant was 
isolated and sequenced (Jiang and Howard, 1992).  Analysis showed that this fragment 
contained two complete genes, exeE and exeF.  To identify the rest of the exe operon, Howard 
et al. (1993) and Howard unpublished results isolated and sequenced an additional ten genes 
which constituted exeC and exeD at the 5’ end of the operon and exeG to exeN at the 3’ end of 
the operon.  Then Kanamycin (kan) resistance cassettes were inserted into three different 
regions of the operon by marker exchange mutagenesis, and analysis indicated that the 
extracellular proteins aerolysin and protease could not be secreted by any of these mutants and 
were instead accumulated in the periplasm.  Moreover, immunoblot and cell fraction 
experiments showed that these mutants displayed altered membrane protein profiles.  This 
phenotype is identical to that of the original Tn5-751 insertion mutant L1.97, indicating that the 
entire operon is required for extracellular secretion.   
 
Another Tn5-751 insertion mutant, C5.84, isolated by Jiang and Howard (1991) displayed the 
same character as the mutant L1.97.  To identify the genes involved, Jahagirdar and Howard 
(1994) isolated and sequenced a 3.5-kb fragment which complemented the C5.84 mutant.  
Subcloning followed by sequence analysis of this fragment revealed that this locus consists of 
an independent operon composed of two genes, exeA and exeB.  Furthermore, complementation 
test showed that both genes were required to restore the mutant to normal extracellular 
secretion, and this result was further confirmed by marker exchange mutagenesis.  In addition, 
in vitro expression and sequence analysis indicated that ExeA is a 60 kDa protein with a 
consensus ATP binding site, and ExeB is a 25 kDa basic protein.  ExeB was later shown to bear 
sequence as well as topological similarity to TonB by Howard et al. (1996).  Both ExeA and 
ExeB fractionate with the IM, and are anchored to the IM by a single hydrophobic domain, with 
large domains localized in the periplasm (Jahagirdar and Howard, 1994; Howard et al., 1996).    
 
1.9  GspA and GspB, secretin assembly factors in the T2SS of A. hydrophila 
Based on the previous results, it can be concluded that ExeA and ExeB, the components of the 
smaller exe operon of A. hydrophila, are two additional proteins required for type II secretion of 
aerolysin and other extracellular proteins.  ExeA and ExeB homologues in T2SS have been 
found in many bacterial species, including V. cholerae, Shewanella putrefaciens, Geobacter 
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sulfurreducens, and E. coli K-12 (Francetic and Pugsley, 1996; Heidelberg et al., 2000; 
Francetic et al., 2000; Sandkvist, 2001a).  OutB of E. chrysanthemi is also an essential 
component for efficient secretion in T2SS, although no OutA has been identified (Condemine 
and Shevchik, 2000).   
 
A series of experiments were done by Howard et al. (1996) to more specially examine the role 
of ExeA and ExeB.  First, site specific mutations of highly conserved amino acids of the ATP-
binding site in ExeA showed that the secretion efficiency of the toxin aerolysin was 
compromised, suggesting that the consensus ATP-binding site is important to the function of 
ExeA.  In addition, an ExeA/ExeB complex was first suggested by examination of the stability 
of ExeB overexpressed in the presence and absence of ExeA.  Specifically, ExeB was protected 
from proteolytic digestion in the presence of ExeA, while degraded when synthesized without 
ExeA.  Based on these results, it can be hypothesized that the role of ExeA may be to provide 
energy by ATP hydrolysis.  This hypothesis was further confirmed by a study of the energetic 
requirements for extracellular secretion.  Letellier et al. (1997) and Wong and Buckley (1989) 
showed that both ATP and protonmotive force are required for secretion across the OM.   
 
Schoenhofen et al. (1998) demonstrated that ExeA formed a stable complex with ExeB in the 
IM via cross-linking and immunoprecipitation.  Pulse-chase immunoprecipitation with ExeA 
anti-serum showed that synthesis of ExeA in the absence of ExeB resulted in rapid degradation 
of ExeA.  In addition, both ExeA and ExeB could be cross-linked into an 85 kDa complex by 
the cross-linking reagent Bis [sulfosuccinimidyl] suberate, and the cross-linked samples could 
then be co-immunoprecipitated with ExeA and ExeB anti-serum, confirming the presence of 
both ExeA and ExeB in the same 85 kDa complex.  ExeA was found to cross-link into a 120 
kDa homodimer as well.  In addition, Schoenhofen et al. (2005) examined the structure of the 
ExeAB complex via gel filtration analysis and suggested that ExeA dimerized and formed a 
very large complex with ExeB which might be comprised of three dimers of each protein and 
that the soluble N-terminal domain of ExeA did not contribute to ExeA mutimerization.   
 
Sequence analysis revealed that ExeA contains three motifs commonly found in kinases.  One 
is a typical Walker A consensus motif or kinase-1a motif, A/GX4GKS/T (50-GEVGTGKT-57), 
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involved in ATP- binding and phosphate-binding and transfer (Walker et al., 1982; Traut, 
1994); and the other two belong to the Walker B motif 126-VVLVD-130,  and the Mg2+ 
binding kinase-2a motifs (105-KLLFD-109)  and kinase-3a motifs (228-GGIPR-232).  To 
examine the role of the potential ATP-binding site in ExeA, Schoenhofen et al. (1998) 
determined the stability of mutations in conserved ATP binding and catalytic residues including 
K56R of kinase-1a motif and G229 of kinase-3a motif with pulse-chase immunoprecipitation.  
The results showed that mutations in the consensus ATP-binding site of ExeA abolish or 
decrease the rate of protein secretion, suggesting that secretion required ATP hydrolysis. 
Schoenhofen et al. (2005) further demonstrated that the purified cytoplasmic domain of ExeA 
(cytExeA), including 278 N-terminal residues, displayed Mg2+ ATPase activity.  Specifically, 
the N-terminal domain of ExeA (cytExeA) with a C-terminal hexahistidine tag containing the 
putative ATP binding/hydrolysis motifs was overproduced in E. coli and purified by metal 
chelate affinity and anion-exchange chromatography.  The malachite green dye-binding assay 
showed that purified cytExeA displayed ATPase activity.   
 
In addition to forming an IM complex with ExeA, ExeB also shows structural and some 
sequence similarity to TonB; this similarity is also found between GspC and TonB (Howard et 
al., 1996).  Moreover, GspB as well as GspC/N have been proposed to interact directly with 
GspD in a TonB-like fashion to open the secretin channel (Howard et al., 1996; Ast et al., 
2002; Filloux, 2004).  TonB is an integral IM protein that translocates various ligands inwardly 
across the OM by opening gated channel proteins in the OM to which the ligands bind.  This 
process is dependent on the electrochemical gradient across the IM.   OutB also has been 
suggested to play an important role in promoting OM insertion and stabilization of the secretin 
oligomer (Condemine and Shevchik, 2000).  Specifically, analysis of OutB showed that a 
mutation in OutB can be suppressed by overproduction of OutD, suggesting that OutB interacts 
with OutD (Condemine and Shevchik, 2000).   Furthermore, OutB can be stabilized in the 
presence of OutD and OutD expressed in E. coli can be protected from proteolytic degradation 
by the coexpression of a fragment of OutB without the N-terminal TMS.  These results were 
further confirmed by cross-linking experiments using formaldehyde.   
The studies described above indicate the ExeAB complex is very important in T2SS protein 
secretion.  Therefore, a series of experiments has been performed to further characterize the role 
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of the ExeAB complex in the T2SS of A. hydrophila (Ast et al., 2002).  Complementation tests 
showed that the secretion deficiency of an exeAB mutant could be overcame by overexpression 
of ExeD.   However, exeC-N operon expression analysis in exeAB mutants showed that the 
ExeAB complex did not regulate the expression or stability of the components of the exeC-N 
operon, and thus did not cause secretion deficiency through a regulatory effect.  Immunoblot 
analysis demonstrated that the ExeD secretin was not able to multimerize and remained in the 
IM as a monomer in the absence of ExeAB.  Furthermore, expression of ExeAB from a plasmid 
in an exeAB mutant strain resulted in an increased amount of ExeD multimer and also restored 
aerolysin secretion.  Pulse-chase radiolabelling experiments also indicated that induction of 
ExeAB complexes could promote the assembly of previously synthesized labelled ExeD 
monomer into the multimer.  All these results suggest that the ExeAB complex is required for 
the assembly and/or multimerization of the ExeD secretin in the OM, possibly using energy 
derived from ATP hydrolysis.  The function of the ExeAB complex in secretin assembly was 
further examined by Howard et al. (2006).  First, a series of two-codon insertion mutants of 
ExeA was constructed and aerolysin secretion assays showed that amino acid 495, located 
within a putative PG binding motif in the peri-ExeA, was required for ExeD secretin assembly 
while not involved in ExeAB complex formation.  That is, the mutant lost the ability to 
assemble the ExeD secretin or secrete aerolysin, while retaining the ability to form a complex 
with ExeB.  This secretion negative phenotype also occurred for substitution mutants of three 
highly conserved amino acids in the PG binding motif, suggesting that the C-terminal PG 
binding domain of ExeA was critical to its function in secretin assembly.  Furthermore, in vivo 
cross-linking with 3, 3´-Dithiobis (sulfosuccinimidylpropionate) showed that WT ExeA could 
be cross-linked to PG, whereas the three substitution mutants of ExeA could not, suggesting 
that there was an interaction between ExeA and PG.  All these experiments suggest that PG 
binding to ExeA is required for the function of the ExeAB complex in ExeD secretin assembly.  
In addition, the in vivo cross-linking analysis also showed that ExeB and ExeC interact with PG 
in the presence of ExeA, suggesting that there are interactions between ExeA and ExeC as well 
as ExeA and ExeB.  All of these results suggest that there may be a complex that involves 
ExeA, B, C, D and PG during assembly of the ExeD secretin. 
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1.10  Research objective of this study 
As described above, many studies have focused on the function of the components of three 
subassemblies, including the IM complex, the OM complex and the periplasmic pseudopilus in 
the T2SS.  However, the IM GspA and GspB proteins are two ancillary factors for secretin 
GspD assembly and/or transport that occur in some bacteria such as A. hydrophila, and the role 
of these two proteins in the T2SS is still not clear.  Previous studies have suggested that GspA 
and GspB play important roles in promoting OM insertion and stabilization of secretin 
multimers (Ast et al., 2002; Howard et al., 2006).  Howard et al. (2006) also revealed that PG 
can be cross-linked to ExeA and that ExeB and ExeC can be cross-linked to PG in the presence 
of ExeA, suggesting that there are interactions between ExeA and ExeC as well as ExeA and 
ExeB.  However, the characterization of GspA and GspB is still not complete and how these 
two proteins link to other components of the T2SS is not yet clear.  Therefore, the research 
objective of this project was to identify and characterize protein-protein interactions between 
GspA, GspB and other components of the T2SS using A. hydrophila as the model bacterium. 
 
The yeast two-hybrid system was used as the experimental approach to identify the protein-
protein interactions.  Although this method has quite a few advantages compared with 
traditional methods, it contains several limitations (Yang et al., 1995; Phizicky and Fields, 
1995; Luban and Goff, 1995).  One of the disadvantages of this method is that highly 
hydrophobic membrane domains may cause insolubility or instability in yeast (Phizicky and 
Fields, 1995; Luban and Goff, 1995; McAlister-Henn et al., 1999).  Therefore, the periplasmic 
domains of Exe proteins were assayed for interactions.  The protein domains selected for the 
yeast two-hybrid assay with ExeA and ExeB were thus based on the topology revealed by 
previous studies.     
 
It has been demonstrated that both ExeA and ExeB are bitopic IM proteins.  The topological 
orientation of ExeA (60 kDa) and ExeB (25 kDa) was determined by Howard et al. (1996) with 
the alkaline phosphatase reporter system.  The results showed that an N-terminal domain of 31 
kDa of ExeA carried the consensus ATP-binding site exposed to the cytoplasm, while a C-
terminal 28 kDa domain extended to the periplasmic space, indicating that ExeA is nearly 
evenly distributed between cytoplasm and periplasm.  For ExeB, only a small N-terminal 
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domain located in the cytoplasm while a large 18 kDa C-terminal domain extended to the 
periplasm, suggesting that the majority of ExeB remains in the periplasm.  Although not well 
studied in A. hydrophila, the topology of the components of the gspC-N operon in other 
bacteria has been studied.  It has been demonstrated that the OM protein GspD contains two 
structurally distinct C-terminal and N-terminal domains, with the N-terminal domain exposed 
to the periplasm where it interacts with other components of the secretion apparatus while the 
C-terminal region containing several putative amphipathic transmembrane β-strands may be 
embedded in the OM and is likely to form the actual channel (Bitter et al., 1998, Brok et al., 
1999; Nouwen et al., 2000).  Except for GspD, the other T2SS components are all IM proteins.  
GspC is a bitopic IM protein which consists of a short N-terminal cytoplasmic sequence, a 
single TMS, and a large hydrophilic periplasmic region (Bleves et al., 1996; Thomas et al., 
1997; Gérard-Vincent, et al., 2002; Robert et al., 2005a; Korotkov et al., 2006).  GspN is a 
homolog of GspC in many species, and thus probably shares the same topology.  Of the IM 
complex components GspE, F, L and M, GspE appears to be associated with the IM on the 
cytoplasmic side (Sandkvist 1995, 2001a) and thus can not be used for the interaction test in the 
periplasm.  GspL contains a single TM helix with a large cytoplasmic domain and a smaller 
periplasmic region (Bleves et al., 1996; Ball et al., 1999; Sandkvist 2000); GspM is a small IM 
protein with a short segment residing in the cytoplasm whereas a larger portion extends into the 
periplasm (Bleves et al., 1996; Sandkvist 2000).  GspF is a polytopic integral cytoplasmic 
protein crossing the IM three times with a small loop in the periplasm and two large segments 
extending into the cytoplasm (Thomas et al., 1997).  Although the pseudopilin proteins G, H, I, 
J and K are found associated with both membranes after fractionation and part of them are in 
the periplasmic space (Sandkvist, 2001a), they may act as a piston and therefore have less 
possibility to interact with ExeAB than other proteins.  Therefore, the periplasmic domains of 
proteins C, D, L, M and N were chosen as the prey for protein-protein interaction studies with 
the baits ExeA and ExeB.   
 
1.11  Yeast two-hybrid experimental strategies 
The Gal4 yeast two-hybrid system was employed to identify protein-protein interactions 
involving Exe proteins.  The yeast two-hybrid system was first described by Stan Fields in 1989 
(Fields and Song, 1989).  It is a genetic method used to identify and analyze protein-protein 
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interactions via transcriptional activity in vivo.  One of the commonly used two-hybrid systems 
is derived from the yeast Gal4 protein.  The intact yeast Gal4 protein is a transcriptional 
activator which consists of two domains: an N-terminal domain which interacts with promoters 
by binding to upstream activation sequences; and a C-terminal domain which interacts with 
polymerase and therefore is necessary to activate transcription.  The system is based on the 
observation that the two domains of the activator need not be covalently linked and can be 
brought together by the interaction of any two fusion protein partners to reconstitute a 
transcriptional activator.  The application of this system requires two hybrid proteins to be 
constructed: one hybrid consists of the Gal4 DNA binding domain fused to a known protein X, 
which is termed the bait; another hybrid consists of the Gal4 activating domain fused to a test 
protein Y or proteins derived from genomic or cDNA libraries which are termed the prey.  If 
binding occurs between the prey and the bait, transcriptional activity will be restored and will 
produce normal Gal4 activity.  This can be detected by expression of reporter genes.  The most 
commonly used reporter genes in the Gal4 system are lacZ and HIS3, which are inserted in the 
yeast genomic DNA immediately after the GAL promoter, so that if binding occurs, LacZ and 
His3 are produced.  
The vectors to be used for the yeast two-hybrid system are pGBT9 (the Gal4 DNA-binding 
domain vector or the bait vector) and pGAD424 (the Gal4 activating domain vector or the prey 
vector) (Bartei et al., 1993a).  One major problem in performing the yeast two-hybrid system is 
the elimination of false positives, clones that cause the activation of reporter genes, but not as a 
result of protein-protein interaction between the bait and the prey.  False positives occur 
frequently in most host strains, such as Y190 and Y153 (Bartei et al., 1993a, b).  In addition all 
these strains use a single promoter element to drive the transcription of the individual reporter 
gene, thus increasing the growth of the background colonies because many false positives are 
specific to the promoter element.  Promoter-specific false positives are even more difficult to 
eliminate due to the utilization of the single promoter element (James et al., 1996).  In this 
project, an improved yeast strain, PJ69-4A was employed in the two-hybrid screens.  This host 
strain was first constructed and described by James, Halladay and Craig in 1996 (James et al., 
1996).  PJ69-4A contains three different reporter genes, including HIS3, ADE2 and lacZ, each 
under control of an appropriate inducible promoter, they are Gal1, Gal2 and Gal7, which can be 
induced to high levels (James et al., 1996).  These promoters respond to the same inducer 
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(Gal4) and share a minimum of sequence identity.  As a result, the ability to discriminate 
between false positives and real interactions is improved.  Among these three reporter genes, 
HIS3 and lacZ have been shown to be extremely sensitive to weak or transient interactions, 
while ADE2 is the most stringent and provides a low background of false positives.   
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2.  MATERIALS AND METHODS  
2.1  Strains and plasmids  
The bacterial and yeast strains used in this study are listed in Table 2-1.   The cloning vectors of 
bacteria and yeast, and recombinant plasmids are listed in Table 2-2A and B.  
2.2 Polymerase chain reaction 
The PCR (polymerase chain reaction) was routinely used to amplify DNA fragments for the 
purposes of cloning, mutagenesis and co-purification.  A PTC-100 programmable thermal 
controller from MJ Research Incorporation (Inc.) (Watertown, MA, USA) and from Mandel 
Scientific (England) were used to carry out routine amplifications.  Annealing temperature 
(temp) gradient PCRs were performed by a PCR machine of Biometra obtained from Montreal 
Biotech Inc. (Montreal, Canada).  
To construct the bait and prey plasmids for the yeast two-hybrid assay,  the Ah65 chromosome 
was used as the template for amplifying the periplasmic domain of exeA, B, C, D,  L, M and N 
(Table 2-3).  Chromosomal DNA was isolated using the following method.  The strain Ah65 
was grown on LB-Agar plate containing 2.5 μg/ml chloramphenicol (Cm) at 30 ºC for 3 days.  
A single colony was picked and resuspended in 500 μl sterile H2O, and then the suspension was 
heated at 95 ºC for 10 min and vortexed to lyse the cells.  PCR reaction mixtures were created 
based on the guidelines in the instruction manual for Pfx DNA polymerase (Invitrogen).  
Specifically, 1 μl of the 500 μl Ah65 chromosomal DNA template was used in a 50 μl reaction 
with a buffer containing 1 × Pfx amplification buffer, 1-2 mM MgSO4, deoxyribonucleotide 
triphosphate (dNTPs) at a final  concentration of 300 μM for each dNTP, 0.4 μM of 
oligonucleotide primer (Table 2-4), and 1.25 unit Pfx DNA polymerase.  The program was 
started with 1 cycle of denaturation (95 ºC, 2 min), then five cycles of denaturation (95 ºC, 1 
min), annealing (the lower temperature listed in Table 2-3) and extension (72 ºC, 1 min), 
followed by twenty five cycles of the same conditions except for the annealing temperature 
used (the higher temperature listed in Table 2-3).   
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TABLE  2-1.  Bacterial and yeast strains 
Strain Genotype/Phenotype Source/Reference 
A. hydrophila   
Ah65 WT This laboratory 
 
E. coli 
  
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)]. 
Stratagene 
 
BL21(DE3) 
 
F– ompT hsdSB (rB– mB–) gal dcm (DE3) 
 
Novagen 
 
Yeast 
  
pJ69-4A MATa trp1-901 leu2-3,112 ura3-52 his3-200 
gal4D gal80D LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
Dr. Wei Xiao 
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TABLE  2-2A.  Bacterial cloning vectors and recombinant plasmids 
Plasmid Description Source/Reference 
pET30a A cloning vector for expression of recombinant 
proteins in E. coli; carries an N-terminal 
His•Tag 
Novagen 
 
pET47b 
 
A cloning vector for expression of recombinant 
proteins in E. coli; carries an N-terminal 
His•Tag coding sequence  
 
Novagen 
 
pCDFDuet 
 
An coexpression vector for two target genes; 
high-level protein expression;  
 
Novagen 
 
pRJ31-1 
 
pVA1.3.1 
 
 
pVA23.6.2 
 
 
pVA2.3.2 
 
 
pVA24.7.1 
 
 
pVA29.2.2 
 
 
pVA6.2.1 
 
 
pVA8.1.1 
 
 
pVA36.1.1 
 
Encodes exeAB sequence 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 58 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 127 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 137 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 182 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 201 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 247 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 256 
 
Encodes exeCD sequence carrying a two-codon 
insertion mutant at amino acid residue 269 
 
Dr. Howard 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
 
 
Vivan Ast 
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TABLE  2-2B.  Yeast cloning vectors  
 Plasmid     Description Source/Reference 
pGBT9 A shuttle vector that replicates autonomously in 
both E. coli and S. cerevisiae; carries the bla 
gene [for ampicillin (Amp) resistance in E. coli] 
and the TRP1 nutritional marker that allow 
yeast auxotrophs carrying pGBT9 to grow on 
limiting synthetic medium lacking Tryptophan 
(Trp);  generates a hybrid protein that contains 
the sequence of  the Gal4 DNA-binding domain 
(GalBD). 
Dr. Xiao 
 
pGAD424 
 
A shuttle vector that replicates autonomously in 
both E. coli and S. cerevisiae; carries the bla 
gene (for Amp resistance in E. coli) and the 
LEU2 nutritional marker that allow yeast 
auxotrophs carrying pGAD424 to grow on 
limiting synthetic medium lacking Leucine 
(Leu);  generates a hybrid protein that contains 
the sequence of  the Gal4 DNA- activation 
domain (GalAD). 
 
Dr. Xiao 
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2-3.  Amplification of fragments for the bait and prey plasmids construction 
Target DNA MgSO4 Conc. Annealing Temp. Resulting clone 
exeA 2 mM 64-68 °C pGBT9-exeA 
pGAD424-exeA 
 
exeB 
 
1 mM 
 
64-68 °C 
 
pGBT9-exeB 
pGAD424-exeB 
 
exeC 
 
  
 1 mM 
 
54-58 °C 
 
pGBT9-exeC 
pGAD424-exeC 
 
  exeD 
 
2 mM 
 
64-68 °C 
 
pGBT9-exeD 
pGAD424-exeD 
 
exeL 
 
1 mM 
 
45-55 °C 
 
pGAD424-exeL 
 
exeM 
 
2 mM 
 
64-68 °C 
 
pGAD424-exeM 
 
exeN 
 
1 mM 
 
58-62 °C 
 
pGAD424-exeN 
 
Note: 
Annealing tempreatures were obtained by oligo design and analysis tools from IDT integrated 
DNA Tecnologies.  Each of the higher tempreature was designed based on the GC content of 
the whole oligo, while each of the lower tempreature was designed based on the GC content of 
the oligo without flanking region. 
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To construct the bait and prey plasmids containing the exeD two-codon insertion mutations, the 
recombinant plasmids carrying the mutations were used as the templates for amplifying the 
eight exeD mutants 1.3, 23.6, 2.3, 24.7, 29.2, 6.2, 8.1 and 36.1 (Table 2-5).  The oligonucleotide 
primer used here is the same as the one use for amplifying exeD (WT) (Table 2-4).  PCR 
reaction mixtures were made according to the guidelines for Pfu DNA polymerase (Fermentas).  
In more detail, 1 μl of 0.2-1 µg/µl plasmid template was used in a 50 μl reaction with a buffer 
containing 10 × Pfu buffer with MgSO4, dNTPs at a final concentration of 300 μM for each 
dNTP, 0.4 μM of oligonucleotide primer, and 1.25 units Pfu DNA polymerase.  The PCR 
program was the same as described above, and the annealing temperature was the same as that 
used for amplifying exeD (64-68 ºC).  The program was started with 1 cycle of denaturation (95 
ºC, 2 min), then five cycles of denaturation (95 ºC, 1 min), annealing (64 ºC) and extension (72 
ºC, 1 min), followed by twenty five cycles of the same conditions except for the annealing 
temperature used (68 ºC).   
 
The target DNAs for cloning of the ExeD deletion mutants (Table 2-6A) were amplified based 
on the guidelines for Phusion Hot Start DNA polymerase (Finnzymes).  In detail, 0.1 μl of 0.2-1 
µg/µl purified plasmid pGBT9-exeD obtained from a miniprep was used as the template in a 10 
μl reaction with a buffer including Phusion HF reaction buffer containing 1.5 mM MgCl2, 
dNTPs at a final concentration of 200 μM for each dNTP, 0.6 μM of oligonucleotide primer 
(Table 2-4), 0.1 μl of Phusion Hot Start DNA polymerase.  For the PCR program, an annealing 
temperature gradient was used as shown in Table 2-6B.  The program started with 1 cycle of 
denaturation (98 ºC, 2 min), followed by four cycles of denaturation (98 ºC, 15 s), annealing 
(Low) (30 s) and extension (72 ºC, 30 s), and 25 cycles of denaturation (98 ºC, 15 s), annealing 
(High) (30 s) and extension (72 ºC, 30 s), and finally an extension of 72 ºC for 5 min.  
 
To construct the bait and the prey for co-purification test, the purified plasmids constructed in 
this study were used as the template (Table 2-7), and PCR reaction mixtures were created 
according to the guidelines for Pfu DNA polymerase (Fermentas).  In more detail, 1 μl of 0.2-1 
µg/µl plasmid template was used in a 50 μl reaction with a buffer containing 10 × Pfu buffer 
with MgSO4, dNTPs at a final concentration of 300 μM for each dNTP, 0.5 μM of 
oligonucleotide primer, 1.25 units Pfu DNA polymerase.  For the PCR program, all the steps 
were as described above except that the annealing temperature was 55-60 ºC.  For pET30-exeA 
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TABLE 2-5.  Amplification of fragments for two-codon insertion mutants of peri-exeD  
 
Target DNA Template Annealing Temp. Resulting clone
exeD (1.3.1) 
 
 
exeD (23.6.2) 
 
 
exeD (2.3.2) 
 
 
exeD (24.7.1) 
 
 
exeD (29.2.2) 
 
 
exeD (6.2.1) 
 
 
exeD (8.1.1) 
 
 
exeD (36.1.1) 
pVA1.3.1 
 
 
pVA23.6.2 
 
 
pVA2.3.2 
 
 
pVA24.7.1 
 
 
pVA29.2.2 
 
 
pVA6.2.1 
 
 
pVA8.1.1 
 
 
pVA36.1.1 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
 
 
64-68 ºC 
pGBT9-exeD (1.3.1) 
pGAD424-exeD (1.3.1) 
pGBT9-exeD (23.6.2) 
pGAD424-exeD (23.6.2) 
pGBT9-exeD (2.3.2) 
pGAD424-exeD (2.3.2) 
pGBT9-exeD (24.7.1) 
pGAD424-exeD (24.7.1) 
pGBT9-exeD (29.2.2) 
pGAD424-exeD (29.2.2) 
pGBT9-exeD (6.2.1) 
pGAD424-exeD (6.2.1) 
pGBT9-exeD (8.1.1) 
pGAD424-exeD (8.1.1) 
pGBT9-exeD (36.1.1) 
pGAD424-exeD (36.1.1) 
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TABLE  2-6A.  Amplification of fragments for constructing the exeD deletion mutants  
Fragments ExeD deletion mutants 
exeD:∆121-355 pGBT9-exeD:∆121-355 
 
exeD:∆26-120 
 
pGBT9-exeD:∆26-120 
 
exeD:∆201-355 
 
pGBT9-exeD:∆201-355 
pGAD424-exeD ∆201-355 
 
exeD:∆26-200 
 
pGBT9-exeD:∆26-200 
pGAD424-exeD:∆26-200 
 
exeD:∆140-355 
 
pGBT9-exeD:∆140-355 
pGAD424-exeD:∆140-355 
 
exeD:∆26-139, ∆257-355 
 
pGBT9-exeD:∆26-139, ∆257-355 
pGAD424-exeD:∆26-139, ∆257-355 
 
exeD:∆26-256 
 
pGBT9-exeD:∆26-256 
pGAD424-exeD:∆26-256 
 
 
 
 
 
 
TABLE  2-6B.  Annealing temperature gradient of PCR for amplification of the exeD 
deletion mutant fragments 
 
 1 2 3 4 5 6 
Low 55.5 ºC 56.9 ºC 60.3 ºC 63.9 ºC 67.4 ºC 70.1 ºC 
High 60.5 ºC 61.9 ºC 65.3 ºC 68.9 ºC 72.4 ºC 75.1 ºC 
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TABLE 2-7.  Amplification of fragments for co-purification expression vectors 
Target DNA Template Annealing Temp. Resulting clone
exeA pRJ31-1 55 ºC pET30-exeA 
exeB pRJ31-1 55 ºC pET30-exeB 
exeC pGBT9-exeC 55-60 ºC pET47-exeC 
exeD pGAD424-exeD 55-60 ºC pET47-exeD 
exeA pGBT9-exeA 55-60 ºC pCDFDuet-exeA 
exeB pGAD424-exeB 55-60 ºC pCDFDuet-exeB 
exeC pGBT9-exeC 55-60 ºC pCDFDuet-exeC 
exeD pGBT9-exeD 55-60 ºC pCDFDuet-exeD 
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and pET30-exeB, diluted plasmid pRJ31-1 was used as the template for amplifying the 
periplasmic domains of exeA and exeB.  The PCR mixture was the same as for the other 
reactions except that 0.4 μM of oligonucleotide primer and 2.5 units of Pfu DNA polymerase 
were used.  The program started with 1 cycle of denaturing (95 ºC, 2 min),  then twenty seven 
cycles of denaturation (95 ºC, 1 min), annealing (55 ºC, 1 min) and extension (72 ºC, 1 min),  
followed by 72 ºC, 3 min.  
 
The PCR fragments were visualized by 1.2% agarose gel electrophoresis as described in 2.4.  
Following confirmation that the PCR products had the expected size, the rest of the PCR 
reaction was purified following 1.2% agarose gel electrophoresis, as described in 2.4. 
 
2.3  Restriction digestion and ligation  
All enzymes used in digestion including EcoRI, BamHI, BglII, MscI, NdeI, XhoI and SacII were 
obtained from New England Biolabs (Pickering, Ontario, Canada), except that AarI was 
obtained from Fermentas (Burlington, Ontario, Canada).  5-10 units of enzyme were used in a 
40 μl reaction.  After 2 h incubation at 37 ºC, the resulting digest was purified by QIAquick 
PCR Purification Kit as described in 2.4.  The purified DNA including the digested PCR 
fragment and the digested vector were then ready for ligation.   
 
T4 DNA ligase and 5 × T4 DNA ligase buffer (Invitrogen, Canada) or T4 DNA ligase and 10 × 
T4 DNA ligase buffer (New England Biolabs) was used for ligation.  The ratio of the vector 
and the DNA insert ranged from 1:4 (1-3 μg/μl) to1:8 (0.2-1 μg/μl) depending on the 
concentration of DNA.  0.5-1.0 μl digested vector and 4 μl digested insert DNA were used in a 
10 μl or 20 μl reaction.  1 μl T4 DNA ligase and T4 DNA ligase buffer was added to the 
mixture.  The ligation mixture was either put in room temperature water bath and the bath then 
placed at 4 ºC overnight, or kept at room temperature for 4 h and then placed at 4 ºC overnight.  
 
2.4  DNA electrophoresis, extraction and purification 
DNA fragments including PCR products and digests of plasmids were separated by 
electrophoresis in 0.8-1.2% agarose in 1 × TBE buffer [0.089 M Tris base, 0.089 M boric acid, 
0.002 M ethylenediaminetetraacetic acid (EDTA), pH8.0].  A constant current of 100 mA was 
applied until the desired migration was reached.  Gels were stained in 0.5 μg/ml ethidium 
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bromide for 5-10 min and then washed with distilled water for 10-20 min.  The DNA was 
viewed at 260 nm by a UV trans-illuminator (Mitsubishi, Japan).   
 
For extraction of PCR fragments, DNA was first isolated by 1.2% agarose gel electrophoresis.  
Then the target fragments were cut from the agarose gel with a surgical blade and put in a 1.5 
ml tube.  The DNA was extracted from the agarose gel using a QIAquick Gel Extraction Kit 
(QIAGEN Science, Maryland, USA), using the protocol supplied with the kit.  DNA digests 
and miniprep plasmids for sequencing were purified using a QIAquick PCR Purification Kit 
(QIAGEN Science, Maryland, USA), using the protocol supplied with the kit.       
 
2.5  Electroporation and transformation  
2.5.1  Electroporation of bacteria 
0.2-1.0 μl plasmid (0.2-2 µg/µl) was added to 40 μl competent bacteria cells.  The mixture was 
transferred to a cold 0.2 mm gap cuvette.  Electroporation was performed at 1.5 volts and the 
time constant was 4.5-4.7.  Recovery media [LB broth (1% tryptone, 0.5% yeast extract, 1% 
NaCl, 10 mM MgCl2, 0.2% glucose] was added immediately to the electroporated cells.  Then 
the culture was mixed by pipetting up and down several times and transferred to a sterile glass 
tube.  The cells were incubated for either 1 h (plasmids encoding Amp resistance) or 2 h 
(plasmids encoding either Kan or streptomycin (Sm) resistance) to increase expression time at 
37 oC.  The culture was then plated on the LB agar plate containing the appropriate 
concentration of antibiotic (100 µg/ml Amp, 50 µg/ml Kan and 50 µg/ml Sm) and incubated at 
37 oC overnight. 
 
2.5.2  Co-transformation of yeast                                                                                                                         
PJ69-4A cells were cultured at 30 °C in a complete YPD medium (5% Bacto YPD Broth).  The 
cells were transformed using a modified dimethyl sulfoxide (DMSO)-enhanced protocol (Hill et 
al., 1991).  For each transformation, approximately 1.7 ml of early log-phase yeast cells were 
pelleted and washed with 400 µl LiTE [0.1 M LiOAc in 1 × TE buffer: 0.1 M lithium acetate 
(Li), 10 mM Tris- HCl, 0.1 mM EDTA, pH 8.0].  The suspension was pelleted again and 
resuspended in 100 µl of LiTE.  An appropriate amount of DNA was then added as well as 4 µl 
of denatured sheared salmon sperm DNA (10 mg/ml in TE).  In addition, 280 µl 50% 
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polyethylene glycol (40% in LiTE) was added and the samples were mixed gently by inversion.  
After incubation at 30 ºC for 4 min, 39 µl 10% DMSO was added and the samples were mixed 
by inverting several times.  The cells were then heat-shocked at 42 ºC for 5 min.  The cells were 
pelleted and the supernatant was removed.  The resulting pellet was washed and resuspended in 
500 µl sterile water.  The cells were pelleted for the last time, and the pellets were resuspended 
in 100 µl sterile water and spread on -Trp-Leu plates (0.67% Difco yeast nitrogen base without 
amino acids, 2% glucose, 2% Difco Bacto agar, amino acid mix, including 20 mg/L Adenine 
(Ade) SO4, 20 mg/L Histidine HCl, 30 mg/L Lysine HCl, 20 mg/L Methionine and 20 mg/L 
Uracil).  Plates were incubated at 30 ºC for 68 h or 72 h to allow colony growth.   
 
2.6  Miniprep plasmid extraction  from E. coli. 
A single colony of positive transformants was inoculated in 2 ml 2 × YT (tryptone 1.6%, yeast 
extract 1%, NaCl 0.5%) with appropriate antibiotic.  The culture was shaken vigorously at 37 
oC for 16-18 h.  The 1.5 ml overnight culture was poured into a tube and centrifuged at room 
temperature for 1 min.  The supernatant was aspirated completely and the pellet was 
resuspended in 200 µl of cold solution I (50 mM glucose, 20.5 mM Tris, 20 mM EDTA, 1% 
RNAse, pH 8.0) and vortexed.  The mixture was kept at room temperature for 5 min.  To lyse 
the cells, 200 μl solution II (0.8% NaOH, 1% SDS) was added, the mixture was gently inverted 
several times, and the tube was placed on ice for 5 min.  Then the base was neutralized by 
adding 200 µl of solution III (3 M KOH, 11.5% glacial acetic acid).  The tube was inverted 
vigorously 5 times and then placed on ice for 15 min.  Then the sample was centrifuged at 4 oC 
for 20 min.  400-500 μl of supernatant was transferred to a new tube containing 250 µl of 
isopropanol.  The tube was inverted vigorously 5 times and then centrifuged at room 
temperature for 20 min.  The supernatant was aspirated completely and the pellet was 
resuspended in 250 µl of cold 70% ethanol, followed by centrifugation at 4 oC for 5 min.  The 
supernatant was aspirated completely and the pellet was dried at 37 ºC for 10 min.  The 
extracted plasmid was resuspended in 25 μl or 50 μl 0.1 × TE buffer (10 mM Tris-HCl, 0.1 mM 
EDTA, pH8.0).  The plasmids were stored at -20 ºC.  The plasmids were then purified as 
described in 2.4.  All centrifuge steps were carried out at 17, 900 × g using Hettich centrifuge 
(Germany).  
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2.7  Plasmid construction 
2.7.1  Yeast two-hybrid constructs of periplasmic exe fragments 
Periplasmic domains of exeA, B, C, D, L, M and N (Table 2-8) were amplified by PCR with 
restriction sites incorporated into the primers as described in 2.2.  In more detail, EcoRI and 
BamHI sites were incorporated into the upstream primer and downstream primer respectively 
for amplifying exeA, B, C, D, L and M.  In addition, EcoRI and BglII sites were incorporated 
into the upstream primer and downstream primer respectively for amplifying exeN since the 
exeN fragment contained a BamHI restriction site.  To construct the bait plasmids, the bait 
vector pGBT9 was double digested with EcoRI and BamHI, and then the PCR fragments of 
exeA, B, C and D containing the EcoRI and BamHI sites were cloned into the vector.  
Similarly, the prey plasmids were made by ligating the exeA, B, C, D, L, M fragments into the 
prey vector pGAD424 (EcoRI and BamHI) as well as inserting the exeN fragment carrying 
EcoRI and Bgl II restriction sites. 
 
2.7.2 Yeast two-hybrid constructs of exeD two-codon mutants  
The 2-codon insertion mutants of exeD were constructed by Vivan Ast using single stranded 
hexameric oligonucleotides (Barany, 1985).  In the peri-exeD encoding region, there are MspI 
(CCGG) and HhaI (GCGC) cohesive end restriction sites (Fig. 2-1, Table 2-9).  Single stranded 
hexameric linkers CGGATC and GATCCG were inserted into 4 MspI and 4 HhaI restriction 
sites in the peri-exeD, thus creating a unique BamHI site.   
 
The 8 fragments of the exeD mutants were amplified by PCR as described in 2.2.  The 2 
primers used were the same as those used for the exeD (WT) fragment.   To construct the bait 
plasmids, the PCR products were digested with EcoRI and MscI and cloned into pGBT-exeD 
(EcoRI and MscI).  Similarly, the prey plasmids were constructed by digesting the PCR 
fragments with EcoRI and AarI and ligating the digests into pGAD424-exeD (EcoRI and AarI).  
 
2.7.3  Yeast two-hybrid constructs of exeD deletion mutants 
To construct the deletion mutants of exeD, seven fragments (Table 2-10) of peri-exeD were 
amplified as described in 2.2.  In more detail, EcoRI/BamHI was incorporated into the upstream 
primers and downstream primers respectively for amplifying all the ExeD fragments.  To 
construct the bait plasmids, the EcoRI and BamHI digested fragments (3-7) were cloned into 
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TABLE  2-8.  Periplasmic domains of Exe fragments 
exe fragments Amino acid residues 
(Whole sequence) 
Amino acid residues 
(Periplasmic domain) 
A 547 288-547 
B 226 38-226 
C 290 47-290 
D 678 26-355 
L 389 273-389 
M 163 41-163 
N 252 37-252 
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1 minkgkgwrl atvaaalmma gsawateysa sfknadieef intvgknlsk tiiieps*vrg 
61 kinvrsydll neeqyyqffl svldvygfav vpmdngvlkv vrskdaktsa ipvvdetnpg 
121 igdemv*trvv pvrnvs*vrel apllrqlndn agggnvvhyd psnvllitgr aavvnrlvev 
181 v*rrvdkagdq evdiiklkya *sagemvrlvt nlnkdgnsqg gntslllapk vvadertnsv 
    241 vvsgep*kara riiqm*vrqld rdlqsqgn*tr vfylkygkak dmvevlkgvs ssieadkkgg 
                301 gtattaggga sigggklais adettnalvi taqpdvmael eqvvakldir raqvlveaii 
FIG. 2-1.  Amino acid sequence of peri-ExeD.  The bold t and l represent the ends of the 
fragment amplified in this study.  *  Insertion sites of the single stranded hexameric linkers 
CGGATC and GATCCG 
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TABLE   2-9.  Linker insertion mutagenesis of peri-exeD    
Plasmid Insertion site (aa) Restriction site
pVA1.3.1 58 HhaI 
pVA23.6.2 127 MspI 
pVA2.3.2 137 HhaI 
pVA24.7.1 182 MspI 
pVA29.2.2 201 MspI 
pVA6.2.1 247 HhaI 
pVA8.1.1 256 HhaI 
pVA36.1.1 269 MspI 
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TABLE  2-10.  Fragments of peri-ExeD for deletion mutants 
Fragment Amino acid residues 
1 26-120 
2 121-355 
3 26- 200 
4 201-355 
5 26-139 
6 140-256 
7 257-355 
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the bait vector pGBT9 (EcoRI and BamHI) and all the 7 fragments were inserted into the prey 
vector pGAD424 (EcoRI and BamHI).  The constructed exeD deletion mutants are listed in 
Table 2-11. 
2.7.4  Construction of vectors encoding tagged and untagged proteins for co-purification 
Co-expression and co-purification assays require a tagged and an untagged protein.  For co-
expression, it is also necessary that the two vectors contain different antibiotic resistance genes 
and plasmid replicons.   In this study, pET30 (Novagen, NJ, USA) and pET47b (Novagen) were 
used as the His-tag vector, and pCDFDuet (Novagen) was used as an S-tag vector in case both 
directions were required.  To construct the N-terminal His-tagged protein,  NdeI/XhoI were 
incorporated into the upstream primers and downstream primers respectively for amplifying 
exeA and B, and SacII and XhoI were incorporated into the upstream primers and downstream 
primers respectively for amplifying exeC and D fragments.  Six his codons were also 
incorporated into the upstream primers for exeA and B for construction of N-terminal His tag.  
pET30a and pET47b were double digested with NdeI and XhoI and SacII and XhoI respectively.  
Then the exeA and B fragments were cloned into pET30a, the exeC and D fragments were 
inserted downstream of the N-terminal His tag sequence of pET47b.  To construct the C-
terminal S-tagged proteins, NdeI and XhoI were incorporated into the upstream primers and 
downstream primers respectively for amplifying exeA, B C and D fragments.  Then the NdeI 
and XhoI double digested fragments were cloned into pCDFDuet (NdeI and XhoI).  In this 
study, the pCDFDuet constructs were used as untagged proteins.  All the primers used in this 
experiment are listed in Table 2-4. 
2.7.5   Determination of the expression of the His-tag fused and unfused protein 
To check the expression of the constructed His tag and S tag Exe proteins, the plasmids were 
electrophorated to BL21 and the transformants induced with Isopropyl β-D-1-
thiogalactopyranoside (IPTG).   Electroporation was accomplished according to 2.5.1.  A single 
colony was picked from each transformation plate containing the appropriate antibiotic and 
resuspended in 2 ml 2 × YT containing 50 µg/ml Kan or 50 µg/ml Sm.  The culture was shaken 
at 37 °C for 16 h.  200 µl over night culture was transferred to 20 ml 2 × YT supplemented with 
appropriate antibiotics.  Cultures were induced with 1 mM IPTG (final concentration) when the  
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TABLE  2-11.  Deletion mutants of pGBT9-exeD and pGAD424-exeD 
 Bait Prey 
1  pGAD424-exeD:∆121-355 
2  pGAD424-exeD:∆26-120 
3 pGBT9-exeD:∆201-355 pGAD424-exeD:∆201-355 
4 pGBT9-exeD:∆26-200 pGAD424-exeD:∆26-200 
5 pGBT9-exeD:∆140-355 pGAD424-exeD:∆140-355 
6 pGBT9-exeD:∆26-139, ∆257-355 pGAD424-exeD:∆26-139, ∆257-355 
     7 pGBT9-exeD:∆26-256 pGAD424-exeD:∆26-256 
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OD600 (optical density) reached 0.6-0.8.  After induction for 3 h, the cultures were centrifuged 
at 8, 820  × g, 4 °C for 10 min, the supernatant was then removed and the pellet was 
resuspended in 10 ml NTA buffer.  10 μg/ml RNase and 20 μg/ml DNase and 40 µl protease 
inhibitor (one tablet/2 ml of redistilled H2O) were added prior to three passes through a French 
Pressure Cell Press (SLM Instruments, INC) at 1, 000 p.s.i.  The lysed cells were centrifuged at 
31, 000 × g for 20 min or 19, 800 × g for 30 min, 4 °C to pellet inclusion bodies and unbroken 
cells.  The supernatant and pellet obtained from the last centrifugation after French Press as 
well as the sample taken before cell collection was used for SDS-PAGE and immunoblot to 
determine the expression of the His-tag fused and unfused Exe proteins.  Rotor JA-17, Avanti J-
E centrifuge (USA) was used in all centrifugation steps. 
2.8 Yeast two-hybrid assay 
The bait and the prey plasmids were co-transformed into pJ69-4A, and initially plated on SD-
Leu-Trp to select for colonies containing both plasmids.  To test the activation of the PGAL1-
HIS3 reporter gene, the cell growth assay was performed where at least six independent 
colonies were grown in SD-Leu-Trp media and then replica plated onto either SD-Trp-Leu-
Histidine (His) alone or SD-Trp-Leu-His containing 3-aminotriazole (3-AT), with a gradient of 
concentration of 0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, 1.0 mM and 1.2 mM.  For the first yeast 
two-hybrid assay, the activation of the PGAL2-ADE2 reporter gene was also determined by 
replica plating onto SD-Leu-Trp-Ade.  At the same time, an auto activation test was performed 
for each fragment to verify if the cloning vector alone would activate the reporter genes.  To do 
so, the bait plasmids and the empty prey vector were co-transformed into strain pJ69-4A as 
were the empty bait vector (pGBT9) and the prey plasmid (pGAD424-exeC-N).  In addition, 
pGBT9-MUS81 and pGAD424-MMS4 were co-transformed into PJ69-4A and was used as the 
positive control while the empty bait vector pGBT9 and the empty prey vector pGAD424 were 
co-transformed into PJ69-4A and used as the negative control.  Plates were incubated for 60 h 
or 72 h at 30 ºC. 
2.9 Co-purification test 
His tag co-purification was performed using FPLC (Fast Protein Liquid Chromatography, 
Amersham Biosciences, AKTA purifier).  pET30-exeA (bait) and pCDFDuet-exeD (prey) were 
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transformed into BL21(DE3) separately.  The two transformants were grown in 20 ml 2 × YT 
contain 50 µg/ml Kan or Sm respectively.  Cultures were induced with 0.4 mM IPTG when the 
OD600 reached 0.6-0.7.  After induction for 3 h, the cultures were centrifuged at 8, 820 × g, 4 °C 
for 10 min, the supernatant was then removed and the pellet was resuspended in 10 ml binding 
buffer [50 mM Tris-HCl, 1 mM phenylmethylsulphonyl fluoride (PMSF), 20 mM imidazol, pH 
7.5].  10 μg/ml RNase and 20 μg/ml DNase and 40 µl protease inhibitor were added prior to 
three passes through a French Pressure at 1, 000 p.s.i.  The lysed cells were centrifuged at 31, 
000 × g for 20 min or 19, 800 × g for 30 min, 4 °C to pellet inclusion bodies and unbroken 
cells.  10 ml of the cell lysate of pET30-exeA and 5 ml pCDFDuet-exeD was applied to a Ni-
NTA agarose column equilibrated with binding buffer (50 mM Tris-HCl, 1 mM PMSF, 20 mM 
imidazol, pH7.5) to detect the His-tag binding of the bait and background binding of the prey 
respectively.  For ExeA and ExeD interaction, 10 ml of the cell lysate of pET30-exeA and 5 ml 
pCDFDuet-exeD was mixed and incubated at 4 °C for 5 h.  The His-tagged bait protein was 
bound to the column and the column was washed with binding buffer before being eluted with a 
gradient of 0 to 100% elution buffer (50 mM Tris-HCl, 1 mM PMSF, 500 mM imidazol, pH 
7.5).  Elution fractions were kept at -20 °C for SDS-PAGE and immunoblot analysis.  Rotor 
JA-17, Avanti J-E centrifuge (USA) was used in all cetrifugation steps. 
2.10 Immunoblot 
In the co-purification experiments of pET30-exeA and pCDFDuet-exeD, the Amersham ECL 
Advance Western Blotting Detection Kit (GE Healthcare, NJ, USA) was used.  The primary 
antibody used was anti-ExeD (1:50,000 dilution), the secondary antibody added was affinity 
purified anti-rabbit (1:100,000 dilution).  To examine the expression of the pGBT9-exeD 
mutants and pGAD424-exeD mutants, the Immun-Star HRP Chemiluminescent Kit obtained 
from Biorad (CA, USA) was used.  The primary antibody used was anti-ExeD (1:20,000 
dilution), the secondary antibody was affinity purified anti-rabbit (1:100,000 dilution).  To 
determine the induction of CDFDuet-exeC, the same protocol was used except that the first 
antibody was anti-ExeC.   
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3.  RESULTS 
 
3.1  Yeast two-hybrid assay of the interactions between ExeA, B and Exe A, B, C, D, L, M 
and N. 
 
Initially, the interactions between the periplasmic domains of ExeA and ExeB and those of 
ExeA, B, C, D, L, M and N were assayed.  The bait plasmids pGBT9-exeA and pGBT9-exeB, 
and the prey plasmids pGAD424-exeC, D, L, M and N were constructed as described in 2.7.1.  
Co-transformation of the baits and the preys into the yeast host strain pJ69-4A and the yeast 
two-hybrid assay were performed as described in 2.5.2 and 2.8.  The results are listed in Table 
3-1.  For the assay between the bait pGBT9-exeA and the prey pGAD424-exeA-N, only 
pGBT9-exeA and pGAD424-exeD showed protein-protein interaction; for pGBT9-exeB and the 
preys, no protein-protein interaction was observed.  Neither pGBT9, the empty bait vector and 
the prey pGAD424-exeA-N, nor the baits pGBT9-exeA and pGBT9-exeB and the empty prey 
vector pGAD424 showed autoactivation except for pGBT9 and pGAD424-exeN (data not 
shown).  Furthermore, the co-transformants of pGBT9-exeA and pGAD424-exeD could not 
grow on SC-Trp-Leu-Ade, and the interaction between pGBT9-exeA and pGAD424-exeD also 
could not be detected by the liquid β-galactosidase assay (data not shown), suggesting the 
interaction between the ExeA and ExeD fragments are weak.  No other protein-protein 
interactions were identified by the yeast two-hybrid assay between ExeA/ExeB and ExeC-N 
except for the ExeA and ExeD interaction.  The negative result for the ExeB and ExeD 
interaction is contradictory to previous studies which have suggested that the C-terminal 
domain including the peri-OutB interacts with OutD (Condemine and Shevchik, 2000).  In 
addition, the ExeAB complex has been demonstrated to play either a direct or indirect role in 
the transport of ExeD into the OM (Ast et al., 2002).   The negative result of ExeA/ExeA and 
ExeA/ExeB was also unexpected as ExeA has been shown to dimerize and to form a very large 
complex with ExeB (Schoenhofen et al., 2005; Howard et al., 2006).  The failure of 
interactions between ExeA/ExeA, ExeB/ExeB and ExeA/ExeB in the yeast two-hybrid assay 
may be because the conformation of these proteins required for interactions cannot be formed 
in yeast.  Another possible explanation of the negative results could be that the protein-protein 
interactions occur in a different region of the proteins.  Since the proteins ExeA and ExeB are 
cytoplasmic membrane proteins, the protein interactions may occur at the TM domain.   
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TABLE 3-1.  Protein-protein interaction in T2SS of                                               
A. hydrophila  identified by yeast two-hybrid assay 1 
 
Bait Prey Interaction 
pGBT9-exeA pGAD424-exeA No 
 pGAD424-exeB No 
 pGAD424-exeC No 
 pGAD424-exeD Yes 
 pGAD424-exeL No 
 pGAD424-exeM No 
 pGAD424-exeN No 
   
pGBT9-exeB pGAD424-exeA No 
 pGAD424-exeB No 
 pGAD424-exeC No 
 pGAD424-exeD No 
 pGAD424-exeL No 
 pGAD424-exeM No 
 pGAD424-exeAN No 
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Similarly, the reason no interactions were identified between ExeA, B and the IM protein ExeC 
as well as the other components of the IM complex, ExeL, M and N  may be because such 
interactions require the N-terminal TM domains instead of C-terminal periplasmic domain or in 
addition to the periplasmic domains.  Previous studies, for example, showed that the N-terminal 
TM domain of GspC interacts with TM domains of other components of the IM complex 
(Bleves et al., 1999; Bouley et al., 2001; Lee et al., 2001; Filloux, 2004). 
 
3.2 Yeast two-hybrid assay of the interactions between ExeC and ExeC, D, L, M and N, 
and between ExeD and ExeA, B, C and D 
 
Based on the assay between ExeA and ExeB and Exe A, B, C, D, L, M and N, a second yeast 
two-hybrid assay was performed to identify interactions between pGBT9-exeC and pGAD424-
exeC, D, L, M and N, as well as pGBT9-exeD and pGAD424-exeA, B, C and D.  The 
interactions between pGBT9-exeD and pGAD424-exeL, M and N were not tested as these three 
proteins are components of the IM complex and less likely to interact with the secretin ExeD.   
pGBT9-exeC and pGBT9-exeD were constructed as described in 2.7.1, and the other plasmids 
as well as the protocol were same as those used in the first assay except that the co-
transformants were not replica plated to SC-Trp-Leu-Ade.  The results are listed in Table 3-2A.  
The results showed that there is an interaction between protein ExeD and protein ExeB and 
ExeC as well as an ExeD self-interaction (Table 3-2A, Fig. 3-1A).  No autoactivation of the 
four protein fragments occurred (Fig. 3-1A).  Furthermore, the interaction occurs between 
pGBT9-exeD and pGAD424-exeB and C, while not in the other direction including pGBT9-
exeB and C and pGAD424-exeD (Table 3-2A, Fig. 3-1B).  Similarly, no interaction was 
observed between pGBT9-exeD and pGAD424-exeA.  This result, together with that of the first 
yeast two-hybrid assay, shows only one-direction interactions between ExeD and ExeA, ExeB 
and ExeC.  This may be because the conformation of the protein required for interactions could 
not be formed in some of the fusion pairs.  Previous studies have shown that the full-length 
GspD forms an oligomeric ring-like structure (Nouwen et al., 2000) that may be required for 
interaction with GspB.  Such an assembly would be unlikely to form in the two-hybrid studies 
but could be present during biochemical approaches such as pull-down experiments or co-
expression and co-purification (Gerard-Vincent et al., 2002).  In addition, the yeast two-hybrid 
system revealed that pGBT9-exeD interacted with pGAD424- exeD, which suggests that ExeD  
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TABLE 3-2A. Protein-protein interactions in T2SS of A. hydrophila identified by yeast 
two-hybrid assay 2 
Bait Prey Interaction 
pGBT9-exeC pGAD424-exeC No 
 pGAD424-exeD No 
 pGAD424-exeL No 
 pGAD424-exeM No 
 pGAD424-exeN No 
   
pGBT9-exeD pGAD424-exeA No 
 pGAD424-exeB Yes 
 pGAD424-exeC Yes 
 pGAD424-exeD Yes 
 
 
 
TABLE 3-2B. The strength of protein-protein interactions in the T2SS of A. hydrophila 
identified by yeast two-hybrid assay 2 
Bait Prey Inhibition by conc. of 3-AT 
pGBT9-MUS81 pGAD424-MMS4 >1.2 mM 
pGBT9-exeA pGAD424-exeD 1.2 mM 
pGBT9-exeD pGAD424-exeB 1.2 mM 
pGBT9-exeD pGAD424-exeC 0.2 mM 
pGBT9-exeD pGAD424-exeD 1.2 mM 
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FIG. 3-1.  ExeD-ExeA/B/C/D two-hybrid interactions.  (A) In vivo interactions of ExeD-
ExeA/B/C/D and autoactivation determined by yeast two-hybrid assay.  Yeast cells pJ69-
4A transformed with Gal4AD and Gal4BD fusion constructs were used to test the interaction.  
Co-transformed plasmids were maintained in the cell by growth on media without Trp and Leu 
(shown on the left of the figure).  Interactions of the hybrid proteins cause the expression of the 
HIS3 reporter which allows growth on minimal medium lacking His since association of the 
Gal4 fusion proteins turns on the GAL1 promoter which transcribes the HIS3 reporter gene.  
Positive interactions are observed on media without His after 60 h incubation at 30 °C (shown 
on the right of the figure).  The table on the left shows the bait and the prey plasmids used in 
the assay.  The pair of pGBT9-MUS81 and pGAD424-MMS4 was used as the positive control, 
while the pair of the empty vectors pGBT9 and pGAD424 was used as the negative control.  
 
 
 
Gal4BD     Gal4AD 
MUS81     MMS4  
vector       vector 
exeA          exeD 
exeD          exeB 
exeD          exeC 
exeD          exeD 
pGBT9     pGAD424 
Growth on SD media  
Trp Leu His–Trp -Leu
vector        exeD 
vector         exeB 
vector        exeC 
exeA         vector
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Fig. 3-1. ExeD-ExeA/B/C/D two-hybrid interactions.  (B) ExeD-ExeA/B/C one-direction 
interactions determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed 
with Gal4AD and Gal4BD fusion constructs were used to test the interaction.  Co-transformed 
plasmids were maintained in the cell by growth on media without Trp and Leu (shown on the 
left of the figure).  Physical interactions of the hybrid proteins cause the expression of the HIS3 
reporter which allows growth on minimal medium lacking His. Positive interactions are 
observed on media without His after 72 h incubation at 30 °C (shown on the right of the figure).  
The table on the left shows the bait and the prey plasmids used in the assay.  The left part and 
the right part of the table show two directions of the assay, using the ExeD fragment as the prey 
and the bait respectively.  The pair of pGBT9-MUS81 and pGAD424-MMS4 was used as the 
positive control, while the pair of the empty vectors pGBT9 and pGAD424 was used as the 
negative control. 
 
 
 
 
 
Growth on SD media  
Gal4BD     Gal4AD
pGBT9     pGAD424 pGBT9     pGAD424
exeA          exeD  
exeB          exeD  
exeC          exeD  
exeD          exeA 
exeD          exeB 
exeD          exeC 
Gal4BD     Gal4AD
MUS81     MMS4  MUS81     MMS4
–Trp -Leu –Trp -Leu -His 
vector         vector  vector        vector
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can multimerize, corresponding to the previous studies showing that GspD is a dodecameric 
structure (Chami et al., 2005).   
The strength of the interactions detected in the first two yeast two-hybrid assays were tested by 
replica plating colonies to SC-Trp-Leu-His containing 0.2-1.2 mM 3-AT (Table 3-2B, Fig. 3-
1C).  The strength of the interaction between ExeD and ExeC was the weakest among the four 
as it is inhibited by lower amounts (0.2 mM) of 3-AT.  The strength of the other 3 interactions, 
including ExeA and ExeD, ExeD and ExeB, and ExeD multimerization are quite similar, and 
can be inhibited by 1.2 mM 3-AT.  However, the interaction between ExeB and ExeD was 
slightly stronger than that of ExeA and ExeD, and the ExeAD interaction is stronger than ExeD 
mutimerization when the plates were examined after one day incubation (data not shown).  
Since the four interactions can be inhibited by 0.2 to 1.2 mM 3-AT, the results indicate that 
they are relatively weak compared with that of the positive control, pGBT9-MUS81 and 
pGAD424-MMS4.  
3.3 Identification of the regions of ExeD involved in protein-protein interactions 
To identify the region of the proteins responsible for the interaction between ExeD and ExeA, 
B, C and D, two-codon insertion mutagenesis (Howard et al., 2006) of the peri-ExeD was 
combined with the two-hybrid assay of ExeD interactions with ExeA, B, C and D.  The two-
codon ExeD mutant fusions were produced as described in 2.7.2, and the location of the 
mutations are shown in Fig. 3-2.  The region of ExeD involved in the interaction between ExeD 
and ExeA, B, C, and ExeD multimerization were identified via yeast two-hybrid assays of the 
two-codon insertion mutants of ExeD and ExeA, B, C in the direction identified by the first 
yeast two-hybrid assay, whereas the region of ExeD responsible for ExeD multimerization was 
identified in both directions (Table 3-3).  At the same time, the autoactivation tests were 
performed.  The protocol was the same as that used in the second yeast two-hybrid assay 
described above. 
 59
 
 
 
 
 
Fig. 3-1. ExeD-ExeA/B/C/D two-hybrid interactions. (C) The strength of the interactions 
determined by the yeast two-hybrid assay.  Co-transformed plasmids were maintained in the 
cell by growth on media without Trp and Leu (shown on the left of the figure).  Positive 
interactions are observed on media without His after 72 h incubation at 30 °C (shown in the 
middle of the figure).  The strength of the interactions was determined with a gradient conc. of 
3-AT added to the media without His (shown on the right of the figure).  The table on the left 
shows the bait and the prey plasmids used in the assay, with the direction in which the positive 
interaction observed.  The pair of pGBT9-MUS81 and pGAD424-MMS4 was used as the 
positive control, while the pair of the empty vectors pGBT9 and pGAD424 was used as the 
negative control. 
 
 
 
 
vector            vector  
–Trp -Leu –His  + 3AT (mM) 
exeA            exeD  
0.2   0.4     0.6      0.8     1.0     1.2 
MUS81         MMS4  
Growth on SD media 
–Trp -Leu –Trp -Leu –His 
Gal4BD     Gal4AD
exeD            exeC  
exeD             exeD  
pGBT9     pGAD424 
exeD            exeB  
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FIG. 3-2.  Linker insertion mutagenesis of peri-exeD.  The gray bar shows the periplasmic 
domain (residue 26-355) of the ExeD protein (residue 1-567).  The mutant number is the name 
of the two-codon mutant constructed by Vivan Ast; A.A insert indicates the amino acids formed 
after two-codon (single stranded hexameric linkers CGGATC or GATCCG) insertion; the 
position shows the MspI or HhaI restriction sites for insertion of the single stranded hexameric 
linkers CGGATC or GATCCG.   
 
 
 
 
 
 
 
 
 
 
 61
TABLE  3-3.  Yeast two-hybrid assays of the interactions between                                             
exeD two-codon mutants and exeA, B, C and D 
Bait Prey 
pGBT9-exeA pGAD424-exeD (mutants) 
pGBT9-exeD (mutants) pGAD424-exeB 
pGBT9-exeD (mutants) pGAD424-exeC 
pGBT9-exeD (mutants) pGAD424-exeD 
pGBT9-exeD pGAD424-exeD (mutants) 
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3.3.1 Yeast two-hybrid assay of the interactions between pGBT9-exeA and pGAD424- 
exeD two-codon mutants 
The first assay performed was between pGBT9-exeA (WT) and the pGAD424-exeD (two-
codon mutants).  The replica plate showed that there are interactions between pGBT9-exeA and 
all of the pGAD424-exeD mutants except for pGAD424-exeD (pVA1.3) (Table 3-4A, Fig. 3-
3A).  Among the interactions, pGBT9-exeA and pGAD424-exeD (pVA36.1) were the strongest, 
the second strongest interaction occurred between pGBT9-exeA and pGAD424-exeD 
(pVA23.6).  The strength of these two interactions was stronger than that of WT, and was not 
completely inhibited by 1.2 mM 3-AT.  The other interactions were inhibited by 0.4-0.8 mM 3-
AT.  The autoactivation test of the positive interactions is shown in Fig. 3-3B.  Autoactivation 
was observed between pGBT9 and pGAD424-exeD (pVA23.6), and between pGBT9 and 
pGAD424-exeD (pVA8.1).  However, compared with the interaction between pGBT9-exeA and 
pGAD424-exeD (pVA23.6), and pGBT9-exeA and pGAD424-exeD (pVA8.1), the 
autoactivations were much weaker (Table 3-4B, Fig. 3-3C).  Therefore, there was still 
interaction between pGBT9-exeA and pGAD424-exeD (pVA23.6), and between pGBT9-exeA 
and pGAD424-exeD (pVA8.1).  Since the interaction between pGBT9-exeA and pGAD424-
exeD (pVA1.3) was completely inhibited, the results suggest that the region from amino acids 
residue 26 to 58 of peri-ExeD (26-355) is involved in the interaction between ExeA and ExeD 
(Fig. 3-4).   In addition, the interaction between ExeA and other ExeD two-codon mutants in 
the fragment of periplasmic domain, ranging from amino acid residue 137 to 256, were partially 
inhibited, especially  the interaction between pGBT9-exeA and pGAD424-exeD (pVA24.7.1) 
which is almost inhibited by 0.2 mM 3-AT.  Therefore, the region around this mutation site 
may also be involved in the protein-protein interaction with ExeA according to these results.  
 
3.3.2 Yeast two-hybrid assay of the interactions between pGBT9-exeD two-codon mutants 
and pGAD424-exeB 
 
The region of ExeD involved in the interaction with ExeB was determined using the yeast two-
hybrid assay between pGBT9-exeD (two-codon mutants) and pGAD424-exeB (WT).  In vivo 
interactions of pGBT9-exeD (two-codon mutants)-pGAD424-exeB (WT) and the strength of  
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TABLE  3-4A.  Interactions between pGBT9-exeA and pGAD424-exeD two-codon 
mutants 
  Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeA pGAD424-exeD >1.2 mM 
pGBT9-exeA pGAD424-exeD (pVA 1.3.1) No interaction 
 pGBT9-exeA *pGAD424-exeD (pVA 23.6.2) >1.2 mM 
pGBT9-exeA pGAD424-exeD (pVA2.3.2) 0.6 mM 
pGBT9-exeA pGAD424-exeD (pVA24.7.1) 0.4 mM 
pGBT9-exeA pGAD424-exeD (pVA29.2.2) 0.8 mM 
pGBT9-exeA pGAD424-exeD (pVA6.2.1) 0.8 mM 
pGBT9-exeA * pGAD424-exeD (pVA8.1.1) 0.6 mM 
pGBT9-exeA pGAD424-exeD (pVA36.1.1) >1.2 mM 
* Autoactivation, the mutant interacts with the vector 
 
TABLE  3-4B.  Autoactivations of pGBT9 and pGAD424-exeD two-codon mutants 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeA pGAD424-exeD >1.2 mM 
pGBT9 pGAD424 No interaction 
pGBT9 pGAD424-exeD (pVA 23.6.2) 0.4 mM 
pGBT9-exeA pGAD424-exeD (pVA 23.6.2) >1.2 mM 
pGBT9 pGAD424-exeD (pVA8.1.1) 0.2 mM 
pGBT9-exeA pGAD424-exeD (pVA8.1.1) 0.4 mM 
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FIG. 3-3.  exeA (WT)-exeD (two-codon mutants) two-hybrid interactions.  (A) In vivo 
interactions of exeA (WT)-exeD (two-codon mutants) and the strength of the interactions 
determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed with Gal4AD and 
Gal4BD fusion constructs were used to test the interaction. Co-transformed plasmids were 
maintained in the cell by growth on media without Trp and Leu (shown on the left of the 
figure).  Positive interactions are observed on media without His after 72 h incubation at 30 °C 
(shown in the middle of the figure).  The strength of the interactions was determined with a 
gradient conc. of 3-AT (0.2-1.2 mM) added to the media without His (shown on the right of the 
figure). The table on the left shows the pairs of pGBT9-exeA (WT) and pGAD424-exeD (two-
codon mutants) used as the bait and the prey plasmid in the assay.  The pair of exeA and exeD 
was used as the positive control, while the pair of the empty vectors pGBT9 and pGAD424 was 
used as the negative control. 
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FIG. 3-3. exeA (WT)-exeD (two-codon mutants) two-hybrid interactions.  (B) 
Autoactivations of the positive interactions determined by the yeast two-hybrid assay.  
The figure on the left shows the positive interactions between pGBT9-exeA (WT) and 
pGAD424-exeD (two-codon mutants), while the figure on the right shows the autoactivation 
test of these interactions.  Co-transformed plasmids were maintained in the cell by growth on 
media without Trp and Leu (left columns of the figure).  Positive interactions are observed on 
media without His after 60 h incubation at 30 °C (right columns of the figure).  The tables on 
the left of each figure list the pairs of pGBT9-exeA (WT) and pGAD424-exeD (two-codon 
mutants) which shows physical interactions and the pairs of vector and WT of exeA/D as well 
as exeD mutants used for the autoactivation test.  The pair of exeA and exeD was used as the 
positive control, while the pair of the empty vectors pGBT9 and pGAD424 was used as the 
negative control.  
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FIG. 3-3. exeA (WT)-exeD (two-codon mutants) two-hybrid interactions.  (C) Comparison 
of the strength of interactions between positive interactions and autoactivations of exeA 
(WT)-exeD (two-codon mutants) by the yeast two-hybrid assay.  Yeast cells pJ69-4A 
transformed with Gal4AD and Gal4BD fusion constructs were used to test the interaction.  Co-
transformed plasmids were maintained in the cell by growth on media without Trp and Leu 
(shown on the left of the figure).  Positive interactions are observed on media without His after 
72 h incubation at 30 °C (shown in the middle of the figure).  The strength of the interactions 
was determined with a gradient conc. of 3-AT (0.2-0.6 mM) added to the media without His 
(shown on the right of the figure).  The table on the left shows the pairs of exeA (WT)-exeD 
mutants used for determining the interaction and vector-exeD mutants used for the 
autoactivation test.  The pair of exeA and exeD was used as the positive control, while the pair 
of the empty vectors pGBT9 and pGAD424 was used as the negative control.   
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FIG. 3-4.  Regions of ExeD involved in the interaction between ExeA and ExeD.   The 
region of ExeD involved in the ExeA-ExeD interaction was determined by the yeast two-hybrid 
assay between ExeA (WT) and ExeD (two-codon mutants).  The vertical arrows show the 
positions of the mutants.  The red arrow stands for complete inhibition of the ExeA-ExeD 
interaction, the purple arrows stand for partial inhibition, and the green arrows stand for no 
inhibition of the interaction.  
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the interactions were shown in Table 3-5 and Fig. 3-5A.  No interaction appeared between the 
first four pGBT9-exeD mutants and pGAD424-exeB, whereas the last four pGBT9-exeD 
mutants showed interaction with pGAD424-exeB.  Among the interactions, the interaction 
between pGBT9-exeD (pVA29.2) and pGAD424-exeB was the strongest, and was only slightly 
inhibited by 1.2 mM 3-AT.  The next strongest was the interaction between pGBT9-exeD 
(pVA36.1) and pGAD424-exeB, which was inhibited by 1.0 mM 3-AT.  The interactions 
between ExeB and the other ExeD mutants were weak, and could be inhibited by 0.2-0.4 mM 
3-AT.  No autoactivation of the positive interactions was observed by the yeast two-hybrid 
assay as shown in Fig. 3-5B.  The interactions between the first four pGBT9-exeD mutants and 
pGAD424-exeB were completely inhibited, suggesting that a region, from amino acid residue 
26-182 of peri-ExeD was responsible for the interaction with ExeB (Fig. 3-6).  However, the 
interaction between pGBT9-exeD (pVA6.2.1) and pGAD424-exeB, and between pGBT9-exeD 
(pVA8.1.1) and pGAD424-exeB are very week, so it can not be excluded that a region, from 
amino acid residue 247 to 256 of peri-ExeD is also involved in the ExeB-ExeD interaction. 
 
3.3.3 Yeast two-hybrid assay of the interactions between pGBT9-exeD two-codon mutants 
and pGAD424-exeC 
 
The yeast two-hybrid assay between pGBT9-exeD (two-codon mutants) and pGAD424-exeC 
(WT) was carried out although the interaction between pGBT9-exeD (WT) and pGAD424-exeC 
(WT) was very weak and sometimes hard to detect.  In vivo interactions of pGBT9-exeD (two-
codon mutants)-pGAD424-exeC (WT) and the strength of the interactions are shown in Table 
3-6 and Fig. 3-7A.  The interactions between seven of eight pGBT9-exeD mutants and 
pGAD424-exeC were hard to detect.  Only pGBT9-exeD (36.1) and pGAD424-exeC showed a 
very weak interaction which was inhibited by 0.2 mM 3-AT.  No autoactivation for this positive 
interaction was observed (Fig. 3-7B).  Therefore, it can be concluded that the interactions 
between all the pGBT9-exeD mutants and pGAD424-exeC were completely inhibited except 
that between pGBT9-exeD (pVA36.1) and pGAD424-exeC, suggesting that the region from 
amino acid residue 26-256 of peri-ExeD is involved in the interaction with ExeC (Fig. 3-8). 
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 TABLE  3-5.  Interactions between pGBT9-exeD two-codon mutants and pGAD424-exeB 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeD pGAD424-exeB >1.2 mM 
pGBT9-exeD (pVA 1.3.1) pGAD424-exeB No interaction 
pGBT9-exeD (pVA 23.6.2) pGAD424-exeB No interaction 
pGBT9-exeD (pVA2.3.2) pGAD424-exeB No interaction 
pGBT9-exeD (pVA24.7.1) pGAD424-exeB No interaction 
pGBT9-exeD (pVA29.2.2) pGAD424-exeB >1.2 mM 
pGBT9-exeD (pVA6.2.1) pGAD424-exeB 0.4 mM 
pGBT9-exeD (pVA8.1.1) pGAD424-exeB 0.2 mM 
pGBT9-exeD (pVA36.1.1) pGAD424-exeB 1.0 mM 
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FIG. 3-5.  exeD (two-codon mutants)-exeB (WT) two-hybrid interactions.  (A) In vivo 
interactions of exeD (two-codon mutants-)-exeB (WT) and the strength of the interactions 
determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed with fusion 
constructs were used to test the interaction. Co-transformed plasmids were maintained in the 
cell by growth on media without Trp and Leu (shown on the left of the figure).  Positive 
interactions are observed on media without His after 72 h incubation at 30 °C (Showing in the 
middle of the figure).  The strength of the interactions was determined with a gradient conc. of 
3-AT (0.2-1.2 mM) added to the media without His (shown on the right of the figure). The table 
on the left shows the pairs of pGAD424-exeD (two-codon mutants) and pGAD424-exeB (WT) 
used as the bait and prey in the assay.  The pair of exeD and exeB was used as the positive 
control, while the pair of the empty vector pGBT9 and pGAD424 was used as the negative 
control. 
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FIG. 3-5.  exeD (two-codon mutants)-exeB (WT) two-hybrid interactions. (B) 
Autoactivation test of the positive interactions by the yeast two-hybrid assay.  The panels 
on the left show the positive interactions between pGAD424-exeD (two-codon mutants) and 
pGAD424-exeB (WT), while the panels on the right show the autoactivation tests of these 
interactions.  Co-transformed plasmids were maintained in the cell by growth on media without 
Trp and Leu (left columns of the figures).  Positive interactions are observed on media without 
His after 60 h incubation at 30 °C (right columns of the figures).  The tables on the left of each 
panel list the pairs of pGAD424-exeD (two-codon mutants) and pGAD424-exeB (WT) which 
shows interactions and the pairs of vector and exeB/D (WT) as well as exeD mutants used for 
the autoactivation test.  The pair of exeD and exeB was used as the positive control, while the 
pair of the empty vectors pGBT9 and pGAD424 was used as the negative control. 
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FIG. 3-6.  Region of ExeD involved in the interaction between ExeD and ExeB.  The region 
of ExeD involved in the ExeD-ExeB interaction was determined by the yeast two-hybrid assay 
between and ExeD (two-codon mutants) and ExeB (WT).  The vertical arrows show the 
position of the mutants.  The red arrow stands for complete inhibition of the ExeA-ExeD 
interaction, the purple arrows stand for partial inhibition, and the green arrows stand for no 
inhibition of the interaction.  
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TABLE  3-6.  Interaction between pGBT9-exeD two-codon mutants and pGAD424-exeC 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeD pGAD424-exeC 0.2 mM 
pGBT9-exeD (pVA 1.3.1) pGAD424-exeC No interaction 
pGBT9-exeD (pVA 23.6.2) pGAD424-exeC No interaction 
pGBT9-exeD (pVA2.3.2) pGAD424-exeC No interaction 
pGBT9-exeD (pVA24.7.1) pGAD424-exeC No interaction 
pGBT9-exeD (pVA29.2.2) pGAD424-exeC No interaction 
pGBT9-exeD (pVA6.2.1) pGAD424-exeC No interaction 
pGBT9-exeD (pVA8.1.1) pGAD424-exeC No interaction 
pGBT9-exeD (pVA36.1.1) pGAD424-exeC 0.2 mM 
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FIG. 3-7.  exeD (two-codon mutants)-exeC (WT) two-hybrid interactions.  (A) In vivo 
interactions of exeD (two-codon mutants-)-exeC (WT) and the strength of the interactions 
determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed with Gal4AD 
and Gal4BD fusion constructs were used to test the interaction. Co-transformed plasmids were 
maintained in the cell by growth on media without Trp and Leu (shown on the left of the 
figure).  Interactions of the hybrid proteins cause the expression of the HIS3 reporter which 
allows growth on minimal medium lacking His.  Positive interactions are observed on media 
without His after 72h incubation at 30 °C (shown in the middle of the figure).  The strength of 
the interactions was determined with a gradient conc. of 3-AT (0.2-0.4 mM) added to the media 
without His (shown on the right of the figure).  The table on the left shows the pairs of 
pGAD424-exeD (two-codon mutants) and pGAD424-exeC (WT) used as the bait and prey in 
the assay.  The pair of exeD and exeC was used as the positive control, while the pair of the 
empty vectors pGBT9 and pGAD424 was used as the negative control. 
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FIG. 3-7.  exeD (two-codon mutants)-exeC (WT) two-hybrid interactions. (B) 
Autoactivation test of the positive interaction by the yeast two-hybrid assay. Yeast cells 
pJ69-4A transformed with Gal4AD and Gal4BD fusion constructs were used to test the 
interaction.  Co-transformed plasmids were maintained in the cell by growth on media without 
Trp and Leu (left column of the figure).  Positive interactions are observed on media without 
His after 60 h incubation at 30 °C (right column of the figure).  The table on the left shows the 
pairs of fragments used in the test.  The pair of vector/exeC and the pair of exeD (36.1)/vector 
are autoactivation tests of the pair of exeD (36.1)/exeC which shows positive interaction. The 
pair of vector/exeC and the pair of exeD/vector are autoactivation tests for the pair of exeD and 
exeC.  The pair of exeD and exeC was used as the positive control, while the pair of the empty 
vectors pGBT9 and pGAD424 was used as the negative control. 
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FIG. 3-8.  Region of ExeD involved in the interaction between ExeD and ExeC.  The region 
of ExeD involved in the ExeD-ExeC interaction was determined by the yeast two-hybrid assay 
between and ExeD (two-codon mutants) and ExeC (WT).  The vertical arrows show the 
position of the mutants.  The red arrow stands for complete inhibition of the ExeD-ExeC 
interaction, the purple arrows stand for partial inhibition.  
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3.3.4   Yeast two-hybrid assay of the interactions between pGBT9-exeD two-codon 
mutants and pGAD424-exeD, and between pGBT9-exeD and pGAD424-exeD two-codon 
mutants 
The region involved in the ExeD dimerization was mapped in both directions by the yeast two-
hybrid assay.  In vivo interactions of pGBT9-exeD (two-codon mutants)-pGAD424-exeD (WT) 
and the strength of the interactions are shown in Table 3-7A and Fig. 3-9.  An interaction 
between pGBT9-exeD (1.3) and pGAD424-exeD, and between pGBT9-exeD (36.1) and 
pGAD424-exeD were observed.  These two interactions appeared stronger than that between 
the WT domains.  The interaction was completely inhibited by all of the other mutations.  In the 
other direction, two-hybrid assay of pGBT9-exeD (WT)-pGAD424-exeD (two-codon mutants) 
is shown in Table 3-7B and Fig. 3-10.  The results indicated that there are three pairs of 
interactions, including pGBT9-exeD and pGAD424-exeD (1.3), pGBT9-exeD and pGAD424-
exeD (23.6), and pGBT9-exeD and pGAD424-exeD (36.1), which were stronger than that of 
WT.  In addition, there was a relatively weak interaction between pGBT9-exeD and pGAD424-
exeD (2.3) which was inhibited by 0.6 mM 3-AT.  In contrast, the interactions between pGBT9-
exeD and the other pGAD424-exeD mutants were completely inhibited.  The autoactivation test 
of the positive interactions in both directions is shown in Fig. 3-11.   Autoactivation was only 
present between the bait vector pGBT9 and pGAD424-exeD (23.6).  The strength of the 
interactions for the positive interaction and for the autoactivation of ExeD (WT) and the ExeD 
(23.6) mutant was determined and compared using 3-AT in the yeast two-hybrid assay (Table 
3-7C, Fig. 3-12).  Although there was autoactivation between pGBT9 and pGAD424-exeD 
(23.6), the interaction between pGBT9-exeD and pGAD424-exeD (pVA23.6) (inhibited by 1.2 
mM 3-AT) was much stronger than the autoactivation (inhibited by 0.2 mM 3-AT), confirming 
the positive interaction between pGBT9-exeD and pGAD424-exeD (pVA23.6).  In addition, the 
same test also found that there is a weak autoactivation between pGBT9 and pGAD424-exeD 
(pVA8.1) which can be inhibited by 0.2 mM 3-AT.  However, neither direction of the yeast 
two-hybrid assay shows an interaction between ExeD (WT) and ExeD (8.1).  Based on the two 
directions of the yeast two-hybrid assays, it can be concluded that from amino acid residue 182 
to 256 of peri-ExeD is involved in the ExeD multimerization (Fig. 3-13). 
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TABLE 3-7A.Interactions between pGBT9-exeD two-codon mutants and pGAD424-exeD 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeD pGAD424-exeD 1.2 mM 
pGBT9-exeD (pVA 1.3.1) pGAD424-exeD >1.2 mM 
pGBT9-exeD (pVA 23.6.2) pGAD424-exeD No interaction 
pGBT9-exeD (pVA2.3.2) pGAD424-exeD No interaction 
pGBT9-exeD (pVA24.7.1) pGAD424-exeD No interaction 
pGBT9-exeD (pVA29.2.2) pGAD424-exeD No interaction 
pGBT9-exeD (pVA6.2.1) pGAD424-exeD No interaction 
pGBT9-exeD (pVA8.1.1) pGAD424-exeD No interaction 
pGBT9-exeD (pVA36.1.1) pGAD424-exeD >1.2mM 
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TABLE 3-7B.  Interactions between pGBT9-exeD and pGAD424-exeD two-codon mutants 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeD pGAD424-exeD 1.2 mM 
pGBT9-exeD pGAD424-exeD (pVA 1.3.1) >1.2 mM 
 pGBT9-exeD * pGAD424-exeD (pVA 23.6.2) >1.2 mM 
pGBT9-exeD pGAD424-exeD (pVA2.3.2) 0.6 mM 
pGBT9-exeD pGAD424-exeD (pVA24.7.1) No interaction 
pGBT9-exeD pGAD424-exeD (pVA29.2.2) No interaction 
pGBT9-exeD pGAD424-exeD (pVA6.2.1) No interaction 
pGBT9-exeD * pGAD424-exeD (pVA8.1.1) No interaction 
pGBT9-exeD pGAD424-exeD (pVA36.1.1) >1.2 mM 
*the mutants can autoactivate with the empty vector 
 
 
TABLE  3-7C.  Autoactivations of pGBT9-exeD and pGAD424-exeD two-codon mutants 
Bait Prey Inhibition by the conc. of 3-AT 
pGBT9-exeD pGAD424-exeD >1.2 
pGBT9 pGAD424 No interaction 
pGBT9 pGAD424-exeD (pVA 23.6.2) 0.2mM 
pGBT9-exeD pGAD424-exeD (pVA 23.6.2) >1.2 
pGBT9 pGAD424-exeD (pVA8.1.1) 0.2mM 
pGBT9-exeD pGAD424-exeD (pVA8.1.1) No interaction 
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FIG. 3-9.  exeD (two-codon mutants)-exeD (WT) two-hybrid interactions.  In vivo 
interactions of exeD (two-codon mutants-)-exeD (WT) and the strength of the interactions were 
determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed with Gal4AD and 
Gal4BD fusion constructs were used to test the interaction.  Co-transformed plasmids were 
maintained in the cell by growth on media without Trp and Leu (shown on the left of the 
figure).  Positive interactions are observed on media without His after 72 h incubation at 30 °C 
(shown in the middle of the figure).  The strength of the interactions was determined with a 
gradient conc. of 3-AT (0.2-1.2 mM) added to the media without His (shown on the right of the 
figure). The table on the left shows the pairs of pGBT9-exeD (two-codon mutants) and 
pGAD424-exeD (WT) used as the bait and prey in the assay.  The pair of exeD and exeD was 
used as the positive control, while the pair of the empty vectors pGBT9 and pGAD424 was 
used as the negative control. 
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FIG. 3-10.  exeD (WT)-exeD (two-codon mutants) two-hybrid interactions.   In vivo 
interactions of exeD (WT)-exeD (two-codon mutants) and the strength of the interactions were 
determined by the yeast two-hybrid assay.  Yeast cells pJ69-4A transformed with Gal4AD and 
Gal4BD fusion constructs were used to test the interaction. Co-transformed plasmids were 
maintained in the cell by growth on media without Trp and Leu (shown on the left of the 
figure).  Positive interactions are observed on media without His after 72 h incubation at 30 °C 
(shown in the middle of the figure).  The strength of the interactions was determined with a 
gradient conc. of 3-AT (0.2-1.2 mM) added to the media without His (shown on the right of the 
figure).  The table on the left shows the pairs of pGBT9-exeD (WT) and pGAD424-exeD (two-
codon mutants) used as the bait and prey in the assay.  The pair of exeD and exeD was used as 
the positive control, while the pair of the empty vectors pGBT9 and pGAD424 was used as the 
negative control. 
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FIG. 3-11.  Autoactivation test of exeD (two-codon mutants)-exeD (WT) and exeD (WT)-
exeD (two-codon mutants).  Autoactivation test of the positive interactions was determined by 
the yeast two-hybrid assay.  The panels on the left show the positive interactions of pGBT9-
exeD (two-codon mutants)-pGAD424-exeD (WT) and pGBT9-exeD (WT)-pGAD424-exeD 
(two-codon mutants), while the panels on the right show the autoactivation test of these 
interactions.  Co-transformed plasmids were maintained in the cell by growth on media without 
Trp and Leu (left columns of the panels).  Positive interactions are observed on media without 
His after 60 h incubation at 30 °C (right columns of the panels).  The table on the left shows the 
pairs of pGBT9-exeD (two-codon mutants) and pGAD424-exeD (WT) as well as the pairs of 
pGBT9-exeD (WT)-pGAD424-exeD (two-codon mutants) used for determination of the 
positive interactions, while the table in the middle shows the pair of vector and WT of exeD as 
well as the exeD mutants used for the autoactivation test.  The pair of exeD and exeD was used 
as the positive control, while the pair of the empty vectors pGBT9 and pGAD424 was used as 
the negative control.  
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FIG. 3-12.  Comparison of the strength of interactions between positive interaction and 
autoactivation of exeD (WT)-exeD (two-codon mutants) by the yeast two-hybrid assay.  
Yeast cells pJ69-4A transformed with Gal4AD and Gal4BD fusion constructs were used to test 
the interaction. Co-transformed plasmids were maintained in the cell by growth on media 
without Trp and Leu (shown on the left of the figure).  Positive interactions are observed on 
media without His after 72 h incubation at 30 °C (shown in the middle of the figure).  The 
strength of the interactions was determined with a gradient conc. of 3-AT (0.2-1.2 mM) added 
to the media without His (shown on the right of the figure).  The table on the left shows the 
pairs of fragment used in the test. The pair of vector/exeD (23.6) and the pair of vector/exeD 
(8.1) show the autoactivation for the exeD-exeD (23.6) and exeD-exeD (8.1) interactions 
respectively.  The pair of exeD and exeD was used as the positive control, while the pair of the 
empty vectors pGBT9 and pGAD424 was used as the negative control.   
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FIG. 3-13. Region of ExeD involved in ExeD multimerization.  The region of ExeD involved 
in the ExeD-ExeD interaction was determined by the yeast two-hybrid assay between and ExeD 
(two-codon mutants) and ExeD (WT) in both directions.  The vertical arrows show the position 
of the mutants.  The red arrow stands for complete inhibition of the ExeA-ExeD interaction, the 
purple arrows stand for partial inhibition, and the green arrows stand for remaining of the 
interaction.  
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3.4 Yeast two-hybrid assay of exeD deletion mutants and exeA, B, C and D 
The yeast two-hybrid assay of the ExeD two-codon mutants identified the regions of ExeD that 
were involved in the interactions; however, the mutations may alter the global structure of the 
proteins, meaning that a two-codon insertion mutation that interferes with the interaction may 
not correctly identify the region involved in that interaction.  Therefore, based on the results of 
the two-hybrid assays, ExeD deletion mutants were constructed and the yeast two-hybrid assay 
was repeated.  To construct the ExeD deletion mutants, the fragments which were suggested to 
be involved in the interactions as well as the regions which did not appear responsible for the 
interactions were cloned into pGBT9 and pGAD424 respectively, as described in 2.7.3.  The 
ExeD deletion mutants used for the assay are shown in Fig. 3-14. 
 
In vivo interactions between ExeA, B C and D (WT) and ExeD (deletion mutants) as well as 
autoactivation of all positive interactions were determined by the yeast two-hybrid assay (Table 
3-8, Fig. 3-15, 3-16 and 3-17).  The results showed that there were interactions between 
pGBT9-exeA and pGAD424-exeD:∆201-355, between pGBT9-exeD:∆201-355 and pGAD424-
exeB, and between pGBT9-exeD:∆201-355 and pGAD424-exeC which indicated that the ExeD 
fragment, from amino acid residue 26 to 200, is involved in the protein-protein interactions 
between secretin ExeD and each of the other components.  No autoactivation of the positive 
interactions occurred in the assay.  The interaction between pGBT9-exeD:∆201-355 and 
pGAD424-exeC was not stable and sometimes could not be observed.  The interaction could 
only be detected when cultures at an OD600 of 7-10 were used (Fig. 3-17).  The interaction was 
even weaker than the GBT9-exeD (WT) and pGAD424-exeC (WT), which is the weakest 
among the interactions determined in this study.  These results correspond to the yeast two-
hybrid assay of the ExeD (two-codon mutants) and ExeA, B and C (WT), which showed 
protein-protein interactions between the respective proteins  and ExeD with mutations in the 
first half of the fragment were completely inhibited while the last half showed weak or medium 
weak interactions.  However, no interaction occurred between pGBT9-exeA and pGAD424-
exeD:∆121-355, perhaps because the structure of the protein fragment was not appropriate for 
the protein-protein interaction in yeast.  Similarly, no interaction was found between the full 
length ExeD protein fragment and any of the ExeD deletion mutants as shown in Table 3-8.   
 86
 
 
FIG. 3-14.  Construction of the peri-exeD deletion mutants.  The grey bar on the top shows 
the peri-exeD, the thinner black bars shows the fragments of exeD used in the assay.  Fragments 
26-120 and 121-355 were cloned into pGBT9 respectively and used as prey for yeast 2-hybrid 
assays of exeA and exeD interactions.  Fragments 26-200 and 201-355 were cloned into both 
pGBT9 and pGAD424 and used as bait and prey for yeast 2-hybrid assays of exeD (deletion 
mutants) and exeA, B, C and D (WT).   In addition, fragments 26-139, 140-256 and 257-355 
were cloned into both pGBT9 and pGAD424 and used as bait and prey for yeast 2-hybrid 
assays of exeD (deletion mutants) and exeD (WT). 
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TABLE  3-8.  Yeast two-hybrid assay between exeD deletion mutants and exeA, B, C, D 
Bait  Prey  Interaction 
pGBT9-exeA pGAD424-exeD:∆121-355 No 
pGBT9-exeA pGAD424-exeD:∆26-120 No 
pGBT9-exeA pGAD424-exeD:∆201-355 Yes 
pGBT9-exeA pGAD424-exeD:∆26-200 No 
pGBT9-exeD:∆201-355 pGAD424-exeB Yes 
pGBT9-exeD:∆26-200 pGAD424-exeB No 
pGBT9-exeD:∆201-355 pGAD424-exeC Yes 
pGBT9-exeD:∆26-200 pGAD424-exeC No 
pGBT9-exeD:∆140-355 pGAD424-exeD No 
pGBT9-exeD:∆26-139, ∆257-355 pGAD424-exeD No 
pGBT9-exeD:∆26-256 pGAD424-exeD No 
pGBT9-exeD pGAD424-exeD:∆140-355 No 
pGBT9-exeD pGAD424-exeD:∆26-139, ∆257-355 No 
pGBT9-exeD pGAD424-exeD:∆26-256 No 
pGBT9-exeD:∆201-355 pGAD424-exeD No 
pGBT9-exeD:∆26-200 pGAD424-exeD No 
pGBT9-exeD pGAD424-exeD:∆201-355 No 
pGBT9-exeD pGAD424-exeD:∆26-200 No 
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FIG. 3-15.  exeA (WT)-exeD (deletion mutants) two-hybrid interaction.  In vivo interactions 
between pGBT9-exeA (WT) and pGAD424-exeD (deletion mutants) as well as the 
autoactivation tests for the positive interaction were determined by the yeast two-hybrid assay.  
Co-transformed plasmids were maintained in the cell by growth on media without Trp and Leu 
(left column of the figure).  Positive interactions are observed on media without His after 60 h 
incubation at 30 °C (right column of the figure).  The table on the left shows the pairs of 
fragment used in the test.  The pair of exeA/vector and the pair of vector/exeD:∆201-355 are 
autoactivation tests of the pair of exeA/exeD:∆201-355 which shows positive interaction.  The 
pair of exeA/vector and the pair of vector/exeD are autoactivation tests of the pair of exeA/exeD 
which was used as the positive control, the pair of the empty vector pGBT9 and pGAD424 was 
used as the negative control. 
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FIG. 3-16.  exeD (deletion mutants)-exeB (WT) two-hybrid interaction.  In vivo interactions 
between pGBT9-exeD (deletion mutants) and pGAD424-exeB (WT) as well as autoactivation 
test for the positive interaction were determined by the yeast two-hybrid assay.  Co-transformed 
plasmids were maintained in the cell by growth on media without Trp and Leu (left column of 
the figure).  Positive interactions are observed on media without His after 60 h incubation at 30 
°C (right column of the figure).  The table on the left shows the pairs of fragments used in the 
test. The pair of exeD:∆201-355/vector and the pair of vector/exeB are autoactivation tests for 
the pair of exeD:∆201-355/exeB which shows positive interaction.  The pair of vector/exeB and 
the pair of exeD/vector are autoactivation tests for the pair of exeD/exeB which was used as the 
positive control, the pair of the empty vector pGBT9 and pGAD424 was used as the negative 
control. 
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FIG. 3-17.  exeD (deletion mutants)-exeC (WT) two-hybrid interaction. Co-transformed 
plasmids were maintained in the cell by growth on media without Trp and Leu (left column of 
the figure).  Positive interactions are observed on media without His after 72 h incubation at 30 
°C (right column of the figure).  The table on the left shows the pairs of fragments used in the 
test.  The pair of vector/exeC and the pair of exeD (36.1)/vector are autoactivation tests for the 
pair of exeD (36.1)/exeC which shows positive interaction. The pair of vector/exeC and the pair 
of exeD/vector are autoactivation test of the pair of exeD/exeC. The pair of exeD and exeC was 
used as the positive control, while the pair of the empty vectors pGBT9 and pGAD424 was 
used as the negative control. 
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3.5 Assay of the interactions between ExeD and ExeA, B, C and D via co-purification 
3.5.1   Induction of the constructed bait and prey plasmids 
In order to further confirm the interactions between the Exe proteins (WT) identified in the 
yeast two-hybrid assays, co-purification tests were performed.  In this experiment, the bait 
plasmids, N-terminal His tag pET30-exeA and exeB, and N-terminal His tag pET47-exeC and 
exeD, as well as the prey plasmids, pCDFDuet-exeA, B, C and D were constructed as described 
in 2.7.4.   Expression of the constructed His tag and S tag Exe proteins were examined as 
described in 2.7.5.  SDS-PAGE showed that all the proteins express well except that 
pCDFDuet-exeC could not be induced (Table 3-9, Fig. 3-18A).   However, the induction of 
pCDFDuet-exeC could be detected by immunoblot (Fig. 3-18B) which indicated that the clone 
was correct but did not express well.  Therefore, pCDFDuet-exeC could not be used for the co-
purification test. 
3.5.2 Co-purification of pET30-exeA and pCDFDuet-exeD  
In order to confirm the positive interactions between ExeD and ExeA, B, C and D identified by 
the yeast two-hybrid assay, the pET30 and pET47b His-tag fused protein and pCDFDuet 
unfused proteins were constructed as described in 2.7.4, and co-purification was assayed in 
both directions using metal-chelate affinity chromatography as described in 2.9.  The samples 
were analysed by SDS-PAGE and immunoblot as described in 2.10.  For pET30-exeA and 
pCDFDuet-exeD, samples comprised of the cell lysate of pET30-exeA (bait), pCDFDuet-exeD 
(prey), and a mixture of pET30-exeA and pCDFDuet-exeD lysates were applied to a Ni-NTA 
column individually.  The sample was then washed with the binding buffer and eluted with 
binding buffer containing 10-500 mM imidazole (Fig. 3-19A).  Fractions A1 to B6 contain the 
flow through of the mixture which contains material not bound to the column (not shown).  A 
peak appears in the elution gradient from fraction C6 to C11 which contains the His-ExeA.  
This peak was also observed in the chart of pET30-exeA alone (data not shown).  Similarly, 
Fig. 3-19B shows the chromatograph for the bait pCDFDuet-exeD.  In this case, a very small 
peak eluted during the elution gradient. 
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TABLE  3-9.  Expression of the Exe proteins 
Lane Sample MW (kDa) Expression 
1-3 pCDFDuet-exeB 20.7 Yes 
4-6 pET30-exeB 19.0 Yes 
7-9 pET47-exeC 27.3 Yes 
10-12 pCDFDuet-exeC 28.7 No 
13-15 pCDFDuet-exeA 30.7 Yes 
16-18 pET30-exeA 30.0 Yes 
19-21 pCDFDuet-exeD 38.2 Yes 
22-24 pET47-exeD 36.8 Yes 
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FIG. 3-18A.  Determination of Exe protein induction by SDS-PAGE.  The His-tag (pET30, 
pET47) and S-tag (pCDFDuet) Exe plasmids were electroporated to BL21 and induced with 1 
mM IPTG for 3 h as described in 2.7.4.  Culture, supernatant (soluble cytoplasmic fraction) and 
pellet (inclusion bodies) of each protein were examined.  Cultures were harvested after 3-h 
induction; supernatants and pellets were collected via centrifugation at 31, 000 × g for 20 min 
or 19, 8000 × g for 20 min after French pressure cell lysis at 1, 000 p.s.i.  Pellets were 
resuspended in 10 ml NTA buffer A.  Samples were mixed with 2 × sample buffer and heated at 
95 ºC for 3 min.  5µl of each sample was loaded on a 12% SDS-PAGE gel.   C: culture, S: 
supernatant, P: pellet.  
 
 
 
 
 
FIG. 3-18B.  Determination of pCDFDuet-exeC induction by immunoblot.   The sample 
used for the blot was the same as the SDS-PAGE of Fig. 3-18A.  The ExeC expression was 
determined by Anti-ExeC immunoblot.  The film was developed for 5 s.  C: culture, S: 
supernatant, P: pellet. 
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FIG. 3-19.  A.  Co-purification of pET30-exeA and pCDFDuet-exeD via FPLC.  BL21 cells 
containing pET30-exeA and pCDFDuet-exeD were induced and extracted as described in 2.9.  
The cell lysates of pET30-exeA and pCDFDuet-exeD were mixed and incubated at 4 °C for 5 h.  
After equilibration of the Ni-NTA agarose column, the mixture was then applied to the column 
which was washed with binding buffer and then eluted with a gradient of binding buffer 
containing 10-500 mM imidazole. B.  Determination of the binding of pCDFDuet-exeD to 
Ni-NTA column.  BL21 cells containing pCDFDuet-exeD were induced and extracted as 
described in 2.9.  The cell lysate was applied to the Ni-NTA agarose column, which was 
washed with binding buffer and then eluted with a gradient of binding buffer containing 10-500 
mM imidazole.  
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SDS-PAGE gels were run on the various column fractions, and the gels stained with coomassie 
blue or used to prepare an anti-ExeD immunoblot.  As shown in Fig. 3-20, the His-ExeA 
fragment of 30 kDa appears in fractions C7 to C11 in the elution of the pET30-exeA and 
pCDFDuet-exeD mixture, with the peak occurring in fraction 9.  This indicates that pET30-
exeA bound to the column properly as the bait.  There is also a prominent ExeD fragment of 
38.2 kDa, in both the pET30-exeA + pCDFDuet-exeD extracts and the flow through fractions, 
indicating that it did not bind to the column as expected.  To determine if small amounts of the 
ExeD fragment had bound to ExeA in the pET30-exeA + pCDFDuet-exeD extracts, an 
immunoblot using anti-ExeD antibody was performed on the peak His-ExeA fractions from the 
pET30-exeA + pCDFDuet-exeD extract fractionation and on the corresponding fractions from 
the pCDFDuet-exeD extract fractionation.  As shown in Fig. 3-21, the 38.2 kDa ExeD fragment 
is observed in the His-ExeA elution fragments, but not in the corresponding fractions when the 
pCDFDuet-exeD extract alone was fractionated on the column.  Therefore, it can be concluded 
that there is an in vitro interaction between ExeA and ExeD, confirming the yeast two-hybrid 
assay results.  
Because the level of apparent ExeD binding was very low, a second co-purification test of 
pET30-exeA and pCDFDuet-exeD was performed with increased amounts of cell lysate.  This 
time 100 ml cultures were grown and the pellet was re-suspended in 5 ml binding buffer.  1 ml 
of the cell lysates or mixed lysates was loaded to the Ni-NTA column.  The chromatographs are 
shown as Fig. 3-22A, B, C.  The SDS-PAGE gels again showed that the 30 kDa His-ExeA 
eluting in the imidazole gradient (Fig. 3-23).  In this case however even on the coomassie blue 
stained gel, a band that appeared to be 38.2 kDa ExeD fragment could be observed in the His-
ExeA peak fractions from the pET30-exeA + pCDFDuet-exeD extracts fractionation.  This 
fragment was also detected in the anti-ExeD immunoblot of the pET30-exeA + pCDFDuet-
exeD extracts imidazole gradient elution fractions, but only very faintly in the corresponding 
elution fractions from the column to which only the pCDFDuet-exeD extract had been applied 
(Fig. 3-24A).   However, the immunoblot revealed a strongly reacting band of 27 kDa and also 
a band of 47 kDa in the pET30-exeA + pCDFDuet-exeD extracts elution fractions.  A further 
anti-ExeD immunoblot on the various extracts showed that the fragment of 27 kDa was neither 
a fragment of ExeD nor a fragment of ExeA because it occurred in the extracts of both pET30-
exeA and pCDFDuet-exeD (Fig. 3-24B).  It co-binds with ExeA but not ExeD because it did  
 96
 
 
FIG. 3-20.  SDS-PAGE of pET30-exeA + pCDFDuet-exeD elution and pCDFDuet-exeD 
elution.  10% SDS-PAGE showing the co-purification of the peri-ExeD expressed from 
pCDFDuet-exeD (38.2 kDa) with the His-tagged peri-ExeA expressed from pET30-exeA (30 
kDa).  The extract and flow through of pET30-exeA + pCDFDuet-exeD, and the imidazole 
gradient elution fractions following the application of a mixture of cell extracts from cells 
containing pET30-exeA + pCDFDuet-exeD are shown on the left, while the extract and flow 
through of pCDFDuet-exeD, the elution fractions of an extract from cells containing only 
pCDFDuet-exeD are shown on the right.    
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FIG. 3-21.  Immunoblot of pET30-exeA + pCDFDuet-exeD elution and pCDFDuet-exeD 
elution.  Anti-ExeD immunoblot showing the co-purification of the peri-ExeD expressed from 
pCDFDuet-exeD (38.2 kDa) with the His-tagged peri-ExeA expressed from pET30-exeA (30 
kDa).  The imidazole gradient elution fractions following the application of a mixture of cell 
extracts from cells containing pET30-exeA and pCDFDuet-exeD are shown on the left, while 
the elution fractions of an extract from cells containing only pCDFDuet-exeD are shown on the 
right.  Anti-ExeD antiserum was used at a dilution of 1:50, 000, and the film was developed for 
3 min.   
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FIG. 3-22A.  Co-purification of pET30-exeA 
and pCDFDuet-exeD via FPLC.  BL21 cells 
containing pET30-exeA and pCDFDuet-exeD 
were induced and extracted as described in 2.9. 
The cell lysates of pET30-exeA and pCDFDuet-
exeD were mixed and incubated at 4° C for 4 h.  
After equilibration of the Ni-NTA agarose 
column, the mixture was applied to the column 
which was washed with binding buffer and then 
eluted with a gradient of binding buffer 
containing 10-500 mM imidazole. 
 
B.  Determination of the binding of pET30-
exeA to Ni-NTA column.  BL21 cells 
containing pET30-exeA were induced and 
extracted as described in 2.9.  After 
equilibration of the Ni-NTA agarose column, 
the cell lysate of pET30-exeA was applied to 
the column which was washed with binding 
buffer and then eluted with a gradient of 
binding buffer containing 10-500 mM 
imidazole. 
 
         C. Determination of the binding of 
pCDFDuet-exeD to Ni-NTA column.  BL21 
cells containing pCDFDuet-exeD were induced 
and extracted as described in 2.9.  After 
equilibration of the Ni-NTA agarose column, 
the cell lysate of pCDFDuet-exeD was applied 
to the column which was washed with binding 
buffer and then eluted with a gradient of 
binding buffer containing 10-500 mM 
imidazole. 
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FIG. 3-23.  SDS-PAGE of pET30-exeA elution and pET30-exeA + pCDFDuet-exeD 
elution.  10% SDS-PAGE showing the co-purification of the peri-ExeD expressed from 
pCDFDuet-exeD (38.2 kDa) with the His-tagged peri-ExeA expressed from pET30-exeA (30 
kDa). The pET30-exeA extract and imidazole gradient elution fractions following the 
application of the cell extract from cells containing pET30-exeA are shown on the left, while 
the pET30-exeA + pCDFDuet-exeD extract and the elution fractions of an extract from cells 
containing pET30-exeA + pCDFDuet-exeD are shown on the right.    
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FIG. 3-24A.  Immunoblot of pET30-exeA + pCDFDuet-exeD elution and pCDFDuet-exeD 
elution.  Anti-ExeD immunoblot showing the co-purification of the peri-ExeD expressed from 
pCDFDuet-exeD (38.2 kDa) with the His-tagged peri-ExeA expressed from pET30-exeA (30 
kDa). The pCDFDuet-exeD extract (1:100 dilution) and the imidazole gradient elution fractions 
following the application of a mixture of cell extracts from cells containing pET30-exeA and 
pCDFDuet-exeD are shown on the left, while the elution fractions of an extract from cells 
containing only pCDFDuet-exeD are shown on the right.  Anti-ExeD antiserum was used at a 
dilution of 1:50, 000, and the film was developed for 3 min. 
 
FIG. 3-24B.  Immunoblot of 26 kDa and 47 kDa fragment.  The pET30-exeA extract (1:10 
dilution), pCDFDuet-exeD extract (1:10 dilution), fraction B6 to B10 of the pET30-exeA lysate 
elution; fraction B7 of the pET30-exeA + pCDFDuet-exeD elution and fraction B7 of 
pCDFDuet-exeD elution are shown.  Anti-ExeD antiserum was used at a dilution of 1:20, 000, 
and the film was developed for 1 min.  
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not occur in pCDFDuet-exeD elution fractions (Fig. 3-24A).  In addition, the fragment of 47 
kDa could not be a fragment of ExeD because it occurred in pET30-exeA extract only (Fig. 3-
24B).  Evidently these proteins co-purify with His-ExeA and also can react with the anti-ExeD 
antiserum.  In addition to these two experiments, other co-purification tests were also 
performed, including examining the interaction between the bait pET30-exeA and the prey 
pCDFDuet-exeA, pCDFDuet-exeB, pCDFDuet-exeC, and the bait pET47-exeD and the prey 
pCDFDuet-exeA.  No other protein-protein interactions could be detected using this method.  
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4.  DISCUSSION 
4.1  The C-terminal periplasmic domains of ExeA and ExeB interact with a region of the 
periplasmic domain of ExeD 
As described in the introduction, the T2SS of A. hydrophila is composed of two operons, 
exeAB and exeC-N (Howard et al., 1993; Jahagirdar and Howard, 1994).  Although ExeA and 
ExeB homologues in T2SS have been found in many bacterial species, their presence is not 
universal (Jahagirdar and Howard, 1994; Condemine and Shevchik, 2000).  Recent studies have 
shown that ExeA and ExeB are two ancillary factors of ExeD in the T2SS of A. hydrophila, 
with ExeA forming a complex with ExeB which is required for the assembly and/or 
multimerization of the ExeD secretin in the OM (Ast et al., 2002; Howard, et al., 2006).  
However, the exact functions of ExeA and ExeB are not clear.  Although ExeB has been 
proposed to interact directly with ExeD in a TonB-like fashion to open the secretin channel 
(Howard et al., 1996; Ast et al., 2002),   no ExeA-ExeD or ExeB-ExeD interactions have been 
observed in our lab.  In Erwinia, OutB was found to stabilize OutD when they were co-
expressed in E. coli and these two proteins could be cross-linked using formaldehyde 
(Condemine and Shevchik, 2000), while no protein-protein interaction has been found between 
GspA and any part of the secreton in other species.   
In this study, yeast two-hybrid assays were used to demonstrate for the first time that both 
ExeA and ExeB interact directly with ExeD.  Specifically, the first group of the yeast two-
hybrid assays was accomplished between the periplasmic domains of ExeA/ExeB (bait) and 
those of Exe A, B, C, D, L, M and N (prey).  The results showed that there was an interaction 
between pGBT9-exeA and pGAD424-exeD, no other interactions were observed.  The negative 
result for the ExeB and ExeD interaction is contradictory to previous studies which have 
suggested that the C-terminal domain including the peri-OutB interacts with OutD (Condemine 
and Shevchik, 2000).  In addition, the ExeAB complex has been demonstrated to play either a 
direct or indirect role in the transport of ExeD into the OM (Ast et al., 2002).  To further 
confirm the results, the yeast two-hybrid assays between ExeD and ExeA/ExeB in the opposite 
direction were performed, and the results showed that there was interaction between pGBT9-
exeD (bait) and pGAD424-exeB (prey) while no protein-protein interaction occurred between 
pGBT9-exeD and pGAD424-exeA. Therefore, it can be concluded that there are protein-protein 
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interactions between ExeA and ExeD, and between ExeB and ExeD, both of which only 
occurred in one direction in the Gal4 yeast two-hybrid system.  This phenomenon might be 
caused by the obstruction of normal structure formation in the Gal4 yeast two-hybrid system.  
Another explanation for the phenomenon could be that oligomerization of the proteins required 
for interactions could not be formed in some of the fusion pairs.  Electron microscopy analysis 
of negatively stained PulD-PulS complexes showed that PulD forms a ring-like structure 
(Nouwen et al., 1999).  The side views of electron microscopy suggested that the protease-
resistant C-terminal domain was composed of two stacked rings and there was protein structure 
in the center of the ring (Nouwen et al., 2000).  A recent study further revealed that the C-
domain contributed to the outer chamber, the central disc and the plug, while the N-terminal 
domain of PulD fold back into the large cavity of the channel formed by the C-terminal domain 
(Chami et al., 2005).  As the result, the full-length GspD in an oligomeric ring-like structure 
may be required for the interaction with other components including GspA, GspB and GspC.  
However, such an assembly is unlikely to form in the Gal4 yeast two-hybrid systems but could 
be present during biochemical approaches such as pulldown experiments or co-expression and 
co-purification (Korotkov et al., 2006).    
The yeast two-hybrid assay showed that the co-transformants of pGBT9-exeA and pGAD424-
exeD could not grow on SC-Trp-Leu-Ade, and that the interaction between pGBT9-exeA and 
pGAD424-exeD could not be detected by the liquid β-galactosidase assay (data not shown), 
indicating that the interaction between the ExeA and ExeD fragments are weak.  The strength 
analysis of the interaction between ExeA and ExeD, and between ExeB and ExeD also 
suggested that both interactions were weak.  To determine the strength of the ExeA-ExeD 
interaction and ExeB-ExeD interaction, the yeast two-hybrid assays were carried out by replica 
plating colonies to SC-Trp-Leu-His containing 0.2-1.2 mM 3-AT.  The results showed that both 
interactions were inhibited by 1.2 mM 3-AT, which is much weaker than the positive control.  
To map the region of ExeD involved in these interactions with ExeA and ExeB, eight two-
codon mutants distributed in the peri-ExeD were constructed and the yeast two-hybrid assay 
were performed between the ExeD (two-codon mutants) and ExeA/ExeB (WT).  The results 
showed that the fragment, from amino acid residue 26 to 58 of ExeD contribute to the 
interaction with ExeA, and that the segment of ExeD, from amino acid residue 26 to182 is 
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involved in the ExeB-ExeD interaction.  This is because the mutations in these two fragments 
completely inhibit the interactions.  In addition, the interaction between ExeA (WT) and the 
ExeD (two-codon mutants) in the fragment from amino acid residue 137 to 256, was partially 
inhibited, especially the interaction between ExeA and the ExeD mutant at residue 182, was 
very weakly inhibited compared with the other strongly inhibited mutant interactions.  
Therefore, it can not be excluded that the region around residue 182 of ExeD may also be 
involved in the interaction with ExeA.  Similarly, a region, from amino acid 247 to 256 of 
ExeD may also be involved in the ExeB-ExeD interaction since the yeast two-hybrid assay 
showed partial inhibition of the interaction between ExeB and mutants in the region of ExeD.  
Although the regions of ExeD that were involved in the interactions with ExeA and ExeB were 
revealed by the yeast two-hybrid assays between the ExeD (two-codon mutants) and 
ExeA/ExeB (WT), a two-codon insertion mutation that interferes with the interaction may not 
correctly identify the region involved in that interaction because the ExeD mutations may alter 
the global structure of the proteins.  Therefore to confirm these results, ExeD deletion mutants 
were constructed and the yeast two-hybrid assay was repeated.  Based on the results of the two-
hybrid assay between ExeD two-codon mutants and ExeA, the region, from residue 26 to 58 of 
ExeD, is involved in the interaction with ExeA, and the region around residue 182 may also be 
important for the interaction, indicating that the fragment, form residue 26 to 120 of ExeD, 
and/or the fragment, from residue 26 to 200 of ExeD, may be important for the ExeA-ExeD 
interaction.  Therefore, four ExeD deletion mutants were constructed, including pGAD424-
exeD:∆121-355, pGAD424-exeD:∆26-120, pGAD424-exeD:∆201-355 and pGAD424-
exeD:∆26-200.   Similarly, the two-hybrid assay between ExeD (two-codon mutants) and ExeB 
(WT) showed that the region from residue 26 to 182 of ExeD, is involved in the interaction 
with ExeB, indicating that the fragment, form residue 26 to 200 of ExeD, may be required for 
the ExeB-ExeD interaction.  Thus two ExeD deletion mutants including pGBT9-exeD:∆201-
355 and pGBT9-exeD:∆26-200 were constructed for the yeast two-hybrid assay.  Although a 
region, from amino acid residue 247 to 256 of ExeD may also be involved in the ExeB-ExeD 
interaction, this fragment is very short and the mutants near this region still showed relatively 
strong interaction with ExeB, therefore this fragment was not used for the ExeD deletion 
analysis.  The yeast two-hybrid assays between the ExeD deletion mutants and ExeA/ExeB 
(WT) showed that there were interactions between pGBT9-exeA and pGAD424-exeD:∆201-
 105
355, and between pGBT9-exeD:∆201-355 and pGAD424-exeB, indicating that the same ExeD 
fragment (amino acid residue 26–200), is involved in the protein-protein interactions with both 
ExeA and ExeB.  This result is consistent with the yeast two-hybrid assays between the ExeD 
two-codon mutants and ExeA/ExeB (WT), which showed protein-protein interactions between 
ExeA/ExeB  and ExeD with mutations in the first half of the fragment were completely 
inhibited while the mutations in the last half of the fragments showed weak or medium weak 
interactions (Fig. 4-1A and B).  Therefore, it can be hypothesized that the region from amino 
acid residue 26 to 200 of the peri-ExeD is involved in the interaction with ExeA and ExeB.  
This corresponds to previous studies showing that the periplasmic N-terminal domain of GspD 
facilitates interactions with other components of the secretion apparatus (Bitter et al., 1998, 
Brok et al., 1999; Nouwen et al., 2000).    
 
Earlier studies showed that ExeA forms a stable complex with ExeB in the IM (Howard et al., 
1996; Schoenhofen et al., 1998).  Schoenhofen et al. (1998, 2005) also suggested that both 
ExeA and ExeB might be homodimers since ExeA could be cross-linked as a 120 kDa 
homodimer and thus the functional ExeAB complex could be a heterotetramer.  These results 
were confirmed by gel filtration analysis of the ExeAB complex indicating that ExeAB was a 
large oligomer possibly consisting of three dimers of each protein (Schoenhofen et al., 2005).  
However, neither self-interaction of ExeA/ExeB nor ExeA-ExeB interaction could be detected 
by the yeast two-hybrid assay.  Similar to the one-direction interaction between ExeA and 
ExeD, and between ExeB and ExeD, the negative results for ExeA-ExeA, ExeB-ExeB and 
ExeA-ExeB interactions could be caused by incorrect folding of the ExeA and ExeB fusion  
protein used in the assay.  Another possible explanation for the negative results might be that 
the protein-protein interaction occurs in a different region of the proteins.  Since ExeA and 
ExeB are cytoplasmic membrane proteins, the protein interactions may occur at the TM 
domain.  In addition, the formation of the ExeAB complex may require dimerization of ExeA 
and ExeB.  However, the conformation of ExeA and ExeB required for self-interactions may 
not have formed in the Gal4 yeast two-hybrid system, thus further resulting in the failure of 
interaction between ExeA and ExeB.   
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FIG. 4-1.  Summary of results indentifying the ExeD region involved in the interaction 
between (A) ExeA and ExeD and between (B) ExeB and ExeD   The region of ExeD 
involved in the ExeA-ExeD and ExeB-ExeD interactions were determined by the yeast two 
hybrid assays between ExeA/ExeB (WT) and ExeD (two-codon mutants) and between 
ExeA/ExeB (WT) and ExeD (deletion mutants) .  The vertical arrows show the position of the 
mutants.  The red arrows indicate complete inhibition of the ExeA-ExeD or ExeB-ExeD 
interaction, the purple arrows indicate partial inhibition, and the green arrows indicate no 
inhibition of the interaction. The black and red bars show the ExeD deletion mutants used in the 
tests.  The red bar stands for the region of ExeD involved in the interactions with ExeA and 
ExeB.    
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In order to confirm the positive interactions identified by the yeast two-hybrid assay, co-
purification assays of ExeD with ExeA/ExeB in both directions were carried out.  When His-
tagged ExeA was used as the bait, the chromatograph and the SDS-PAGE gels showed that the 
His-tagged ExeA bound to the column properly, and immunoblot using anti-ExeD antibody 
showed that the ExeD fragment (pCDFDuet-exeD) bound to the His-ExeA since the ExeD 
fragment was observed in the elution fraction when pET30-exeA + pCDFDuet-exeD extracts 
were incubated together before application to the column.  Thus the results indicated that there 
is an in vitro interaction between ExeA and ExeD, confirming the results of the yeast two-
hybrid assay.  Unfortunately, the ExeA-ExeD interaction in the other direction (pET47-exeD 
and pCDFDuet-exeA) and the ExeD-ExeB interactions could not be confirmed via co-
purification due to background binding.  This phenomenon often occurs when the interactions 
are weak, as was indicated by the yeast two-hybrid assay in this study.  
 
An earlier study in our lab has proved that ExeAB complex is required for the localization and 
assembly of the ExeD secretion port multimer in the OM (Ast et al., 2002).  This is based on a 
series of experiments  showing that the ExeD secretin was not able to multimerize and 
remained in the IM as a monomer in the absence of ExeAB, however, expression of ExeAB 
from a plasmid in an exeAB mutant strain resulted in an increased amount of ExeD multimer 
corresponding to the restored aerolysin secretion.  Moreover, induction of ExeAB complexes 
could promote the assembly of previously synthesized ExeD monomer into the multimer.  The 
same study also found that overproduced ExeD in C5.84 cells, an exeA::Tn5-751 mutant, 
would result in ExeD  multimerization in the IM without the presence of ExeAB, and the 
amount fractionated with the OM of the overproducing cells was similar to that in WT.  This 
result further suggests that the ExeAB complex plays either a direct or indirect role in the 
transport of ExeD into the OM, probably via interacting directly with ExeD.  The function of 
the ExeAB complex in secretin assembly was further examined by Howard et al. (2006) and the 
result showed that mutations in a putative PG binding motif in the peri-ExeA lost the ability to 
assemble the ExeD secretin or secrete aerolysin, while retaining the ability to form a complex 
with ExeB, suggesting that the PG binding motif of ExeA was required for ExeD secretin 
assembly while not involved in ExeAB complex formation.  The study also revealed that ExeA 
(WT) could be cross-linked to PG, whereas three substitution mutants in the putative PG 
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binding motif of ExeA could not, indicating that there was an interaction between ExeA and 
PG.  Therefore, it can be concluded that PG binding to ExeA is required for the function of the 
ExeAB complex in ExeD secretin assembly.  In addition, the in vivo cross-linking analysis also 
showed that ExeB and ExeC interact with PG in the presence of ExeA. This result leads to a 
hypothesis that ExeA, B, C, D and PG may form a complex during assembly of the ExeD 
secretin.  Therefore, the ExeABCD-PG complex is probably involved in localization and 
assembly of the ExeD secretion port multimer in the OM.  However, no interaction was 
identified between ExeA and ExeC and between ExeB and ExeC in the yeast two-hybrid assays 
described here.  This could be because the regions and structures of ExeA, B and C involved in 
such interactions were not present in these assays.  The C-terminal periplasmic domain of 
ExeA, ExeB and ExeC would be presumed to be involved in the interactions as a previous 
study suggested that both PDZ domain of PulC and coiled coil structure of GspC in the 
periplasm were involved in the protein-protein interactions (Bleves et al., 1999; Bouley et al., 
2001; Gérard-Vincent, et al., 2002; van Ham and Hendriks, 2003).  In contrast, other studies 
showed that both the coiled coil structure and the PDZ domain of GspC could be involved in 
the formation of homo-multimeric complexes (DaeGérard-Vincent et al., 2002) or contribute to 
the recognition of secreted proteins and confer secretion specificity to a subgroup of secreted 
proteins (Bouley et al., 2001), indicating that the C-terminal coiled coil structure and the PDZ 
domain of GspC might not be required for interaction with other proteins of T2SS. Moreover, 
other studies suggested that the TMS and/or N-terminal cytoplasmic domain of GspC formed a 
complex with GspL and GspM (DaeGérard-Vincent et al. 2002; Lee et al. 2004), and it could 
be that these two domains of ExeC may be responsible for interactions with ExeA and ExeB.  
In the study of Howard et al. (2006), full length ExeA, ExeB and ExeC (WT) were used and the 
interactions of ExeA/PG, ExeB/PG and ExeC/PG were detected by in vivo cross-linking and 
immunoblot with anti-ExeA, anti-ExeB and anti-ExeC individually.  In this study, only the C-
terminal periplasmic domains of the three proteins were cloned into the yeast vector for the 
two-hybrid assay.  Therefore, possible interactions between ExeA and ExeC and between ExeB 
and ExeC might not have been detected due to the deletion of TMS and cytoplasmic domain of 
the proteins.  In addition, GspC has also been shown to form a homo-trimer or homo-multimer 
in the IM via the C-terminal coiled coil/PDZ domain or TMS (Possot et al., 1999, DaeGérard-
Vincent et al., 2002, Login and Shevchik, 2006).  Therefore it is also possible that the 
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mutimerization of ExeC is required for any interaction with ExeA and ExeB, and this 
mutimerization might not have occurred in the yeast two-hybrid system. 
 
4.2 The C-terminal periplasmic domain of ExeC interacts with the N-terminal 
periplasmic domain of ExeD  
 
In addition to ExeA and ExeB, ExeC and secretin ExeD also form important protein-protein 
interactions in the T2SS according to previous work.  It has been suggested that GspC and 
GspD are essential for toxin secretion in T2SS as they confer specificity for substrate 
recognition and/or secreton assembly (Gerard-Vincent et al., 2002), and evidence for GspC and 
GspD interactions has been reported (Shevchik et al., 1997; Possot et al., 1999; Lee et al., 
2000; Johnson et al., 2006).  In this study, the yeast two-hybrid assay showed that there was a 
very weak interaction between ExeC and ExeD which could be inhibited by 0.2 mM 3-AT, 
confirming the ExeC-D interaction in A. hydrophila.  However, previous results have shown 
discrepancies concerning the region of GspC involved in the interaction with GspD.  Most 
studies suggest that C-terminal peri-GspC is involved in the interaction with GspD (Bleves et 
al., 1999; Gerard-Vincent et al., 2002; Robert et al., 2005a; Korotkov et al., 2006).  In this 
study, the peri-ExeC, from amino acid residue 47 to 290, was used for the yeast two-hybrid 
assay and the positive result corresponds to previous studies mentioned above.  Based on the 
studies described in the introduction, it can be hypothesized that the high homology region in 
the peri-ExeC is important for the interaction with ExeD.  In addition, the region of ExeD 
involved in the interaction with ExeC was also examined by the yeast two-hybrid assay 
between ExeD (two-codon mutants) and ExeC (WT) and between ExeD (deletion mutants) and 
ExeC (WT).  The yeast two-hybrid assay between the ExeD two-codon mutants and ExeC 
suggested that the fragment containing amino acid residue 26-256 of peri-ExeD is involved in 
the interaction with ExeC.  Similarly, the yeast two-hybrid assay between the ExeD deletion 
mutants and ExeC also showed that a region in peri-ExeD, from amino acid residue 26 to 200, 
is probably responsible for the interaction with ExeC.  However, since the interaction between 
the ExeD mutants and ExeC is very weak and not stable, the exact region of ExeD that 
contributes to the ExeC-ExeD interaction could not be determined in this study.  Although the 
exact region of ExeD involved was not mapped, the positive result of the ExeC-D interaction is 
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consistent with most studies suggesting that the N-terminal peri-GspD is involved in protein-
protein interactions with ExeC (Bitter et al., 1998, Brok et al., 1999; Nouwen et al., 2000).   
 
Previous studies suggested that the C-terminal coiled coil/PDZ domain of GspC could be 
involved in the formation of homo-multimeric complexes (DaeGérard-Vincent et al., 2002).  
However, in this study, self-interaction of ExeC was not observed in the yeast two-hybrid 
assay, which corresponds to recent studies indicating that the TM domain drives the self-
association of GspC whereas the periplasmic region is dispensable for homodimerization 
(Robert et al. 2005a; Korotkov et al. 2006; Login and Shevchik 2006).   
Interactions between ExeC and ExeL/ExeM were also not observed using the yeast two-hybrid 
assay in this study.  The negative result is contradictory to previous studies showing that GspC 
could associate with the IM proteins GspL and GspM and stabilize the GspLM subcomplex 
(Possot et al., 1999, 2000; Gérard-Vincent et al., 2002; Robert et al., 2002, 2005b; Lee et al., 
2004).  This discrepancy might be caused by the region of ExeC used in the assay.  Many 
studies have suggested that the N-terminal TM domain and/or TM/HR domain of GspC 
interacts with the components of the IM complex (Bleves et al., 1999; Bouley et al., 2001; Lee 
et al., 2001; Gerard-Vincent et al., 2002), while other studies suggested that the N-terminal 
cytoplasmic domain of GspC is required for the interaction with GspLM and stabilization of the 
IM complex.  In this study, however, only the peri-ExeC was used for the yeast two-hybrid 
assay.   
4.3  Residue 182 to 256 of the periplasmic domain of ExeD contributes to the 
multimerization of ExeD. 
In this study, the N-terminal periplasmic domain, from amino acid residue 26 to 355 of ExeD 
was found to be able to dimerize in the Gal4 yeast system.  Compared with the positive control, 
the interaction is very weak and can be inhibited by 1.2 mM 3AT.  This result corresponds to 
previous studies showing that the secretin GspD forms a highly stable large oligomeric ring in 
the OM which consists of approximately 12-14 monomers (Bitter et al., 1998; Nouwen et al., 
1999, 2000; Chami et al., 2005).  However, most studies have suggested that the C-terminal 
domain of GspD is responsible for OM insertion and multimerization (Chen et al., 1996; 
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Shevchik et al., 1997; Bitter et al., 1998, Brok et al., 1999; Nouwen et al., 2000; Bouley et al., 
2001).  Chen et al. (1996) for example revealed that two fragments, from residue 429 to 544 
and from residue 544 to 759 in the C-terminal domain of XpsD were required for OM insertion 
and multimerization.  However, Guilvout et al. (1999) suggested that both the N-terminal and 
C-terminal region of PulD were required for multimerization.  The study found that the C-
terminal domain is responsible for multimer stability while the N domain contributes to 
multimer formation.  Moreover, Chami et al. (2005) also suggested that only a small part of C-
terminal domain of PulD was embedded within the OM, suggesting that the N-terminal domain 
of PulD might also be involved in homo-multimerization.  Therefore, it can be hypothesized 
that the periplasmic N-terminal domain of GspD is also involved in the mutimerization in 
addition to interacting with other components of the T2SS.  In addition, the exact region of the 
ExeD involved in the ExeD dimerization was further mapped using the yeast two-hybrid assay 
between ExeD (two-codon mutants) and ExeD (WT), and the result showed that the region 
from amino acid residue 182 to 256 of peri-ExeD is involved in the ExeD multimerization.  
This result, together with the results concerning the interactions between ExeD and ExeA and B 
lead to the hypothesis that the region from amino acid residue 26 to 200 of peri-ExeD is 
involved in the interaction with other components of the secretion apparatus and exoproteins in 
the periplasm while the region from amino acid residue 182 to 256 of peri-ExeD contributes to 
the multimerization of ExeD in addition to the C-terminal domain of ExeD.  The region of 
ExeD involved in the dimerization of ExeD could not be examined by the yeast two-hybrid 
assay between ExeD (deletion mutants) and ExeD (WT), this is probably because the self-
interaction requires full length or a longer sequence of ExeD to form the dimer in the yeast, the 
lack of these sequences resulting in the structure needed for the interaction not being formed in 
the yeast.  
 
4.4   A hypothetical model for the type II secretion apparatus of A. hydrophila 
Base on the previous results and the findings in this study, a model of the T2SS of A. 
hydrophila is described as follows.  The T2SS is part of the GSP which includes 2 steps, 
passage across the inner and outer membranes (Fig. 1-1).  In the first step, exoproteins to be 
secreted such as aerolysin are synthesized as precursors containing N-terminal cleavable signal 
peptides that target them to the Sec machinery in the IM.  Following secretion into the 
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periplasm, signal peptides are removed by the activity of leader peptidase, and the mature 
exoproteins are released into the periplasmic space, where they fold.  In the second step, the 
fully folded exoproteins in the periplasm are recognized and translocated across the OM by 
components of the T2SS.  This process is accomplished by the coordination of the ExeEFLM 
complex, ExeABCD-PG complex and the pseudopilus structure composed of ExeG-K.  First, 
the IM proteins ExeL and ExeM assemble into homomultimers and protect each other from 
proteolytic degradation via direct interaction.  At the same time, the cytoplasmic protein ExeE 
arranges itself into a hexameric ring which leads to its association with the N-terminal 
cytoplasmic domain of ExeL.  ExeE oligomerization might be triggered by ATP binding, and 
ATPase activity might require a properly formed conformation of EpsE resulting from 
association of ExeE and ExeL.  The IM protein ExeF also joins the complex via interacting 
with the ExeE hexameric ring and ExeL homomultimer and is stabilized by these two proteins.  
ExeC strengthens the association between ExeL and ExeM via forming a reversible ternary 
complex with these two proteins. The resulting IM complex formed of ExeE, ExeF, ExeL and 
ExeM via a reversible association is thus used as a platform for assembling the pseudopilus 
composed of ExeG to ExeK.  During the formation of the ExeE, F, L and M complex, ExeA, 
another ATPase in addition to ExeE in the T2SS of A. hydrophila, triggers the formation of a 
large and stable complex composed of three ExeA dimmers and three ExeB dimers in the IM 
via ATP-binding to its consensus ATP-binding site .  At the same time, ExeA and ExeB bind to 
PG.  During this process, ExeAB interact directly with the amino-terminal domain of ExeD, 
leading to the assembly and multimerization of the secretin into the PG and OM.  These 
activities may be triggered or regulated using energy derived from ATP hydrolysis.   In 
addition, ExeC and ExeN connect the IM complex ExeEFLM and the OM by interacting with 
ExeLM of the IM complex and the OM protein ExeD.  ExeB, ExeC and ExeN may control the 
opening of the ExeD secretin channel directly or via interacting with ExeD in a TonB-like 
fashion to open the secretin channel, leading to efficient secretion.  The pseudopilins composed 
of ExeG to ExeK extend from the ExeEFLM complex and form a pilus structure spanning the 
cell envelope to the ExeD pore of the OM.  During the secretion process, ExeG is assembled in 
the pseudopilus and interacts directly with the secretin ExeD, a process dependent on ExeN via 
ExeG-ExeN interaction.  ExeC may also play a direct role during pseudopilus assembly or 
activity by regulating the ExeG-ExeD contact.  The pseudopilus assembly and elongation 
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process is controlled by ExeK via interactions with ExeG.  ExeK forms a ternary complex with 
ExeI and ExeJ and the complex might locate at the tip of the pseudopilus.  Once the T2SS is 
assembled, the exoproteins in the periplasm are recognized by ExeD, and ExeK-ExeI-ExeJ tip 
probably interacts transiently with the secretin ExeD,   thus acting as a piston to translocate 
exoproteins out of the cell through the OM secretin pore.   
 
5.  FUTURE WORK 
In this study, four pairs of protein-protein interactions including ExeA-ExeD, ExeD-ExeB, 
ExeD-ExeC and ExeD-ExeD, were identified by the Gal4 yeast two hybrid system.  However, 
some interactions which were expected were not obtained, for example between ExeA and 
ExeB.  As previously discussed this may be because either the regions of the proteins used for 
the tests were not involved in the interaction or the conformation of the proteins required for 
interactions could not be formed in some of the fusion pairs in the yeast two-hybrid system.  In 
addition, some of the interactions observed were not stable and the system was not sensitive 
enough for some of the weak interactions between Exe proteins.  For these reasons, a bacterial 
two-hybrid system is suggested as an alternative for future study.  The BacterioMatch II two-
hybrid system has been proved to be an efficient method for detecting protein-protein 
interactions in vivo (Wu et al., 2003).  Protein-protein interaction is examined via 
transcriptional activation of his3, the first reporter gene, which allows growth in the absence of 
histidine.  Positives are verified by the secondary reporter aadA gene, which confers Sm 
resistance.  Compared with the yeast two-hybrid system, the bacterial two-hybrid system has 
the following advantages: First, it may take less time due to the much faster growth of bacteria 
compared to yeast; second, higher efficiency of transformation can result in larger numbers of 
interactions being screened more rapidly and easily, and third, easier isolation of plasmid DNA 
from E. coli than from yeast.  
 
In this study, both pull-down (data not shown) and co-purification were performed to verify the 
yeast two-hybrid result.  Certain protein structures or assembly required for the protein-protein 
interaction might be unable to form in the two-hybrid studies but could be present during 
biochemical approaches such as pull-down experiments or co-expression and co-purification 
(Korotkov et al., 2006).   For example, the full-length GspD forms an oligomeric ring-like 
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structure.  However, there was always background binding in both methods.  Therefore, another 
method is necessary for confirming the protein-protein interactions between Exe proteins.  In 
vivo cross-linking with bifunctional cross-linking reagents between the full length Exe proteins 
would be one way to confirm the interactions observed in this study.  One problem however is 
that the full length ExeD is a highly stable large oligomer, which may be diffcult to identify the 
ExeA-ExeD interaction on the SDS-PAGE gel and immunoblot since the large protein complex 
of ExeA + ExeD multimer would be at the very top of the gel.  Therefore, trichloroacetic acid 
(TCA) or phenol could be used to break the ExeD oligomer into monomers for the analysis.  To 
identify the protein-protein interaction between ExeA or ExeB and ExeD, A. hydrophila 
containing full length ExeD (WT) and ExeA (WT) would be grown and cross-linking reagent 
would be added.  After phenol or TCA extraction, ExeA and ExeD would be 
immunoprecipitated by anti-ExeA and anti-ExeD antibody irrespectively.  If there is protein-
protein interaction, in addition to the presence of full length ExeA and monomer ExeD in the 
precipitates, complexes reacting with both antiserum would be observed.  This would also 
involve full length Exe proteins compared to the fragments used in this study.  
 
In this study, the interacting region of the N terminal domain of ExeD has been mapped via the 
yeast two-hybrid assay between the ExeD (two-codon mutants) and ExeA, B, C and D (WT), 
and between the ExeD (deletion mutants) and ExeA, B, C and D (WT).  Based on these results, 
the ExeD fragment, from amino acid residue 26 to 200, is proposed to be involved in the 
protein-protein interaction with ExeA, B and C, which may contribute to ExeD assembly and to 
function of the T2SS.  To confirm the importance of these interactions to T2SS function, a 
complementation test of the ExeD (two-codon mutants) used in this study could be performed 
and the effect on ExeD assembly determined.  To do so, the ExeD two-codon mutants could be 
cloned to pVACD-P, a plasmid containing ExeD in pMMB207 constructed by Vivan Ast (Ast 
et al., 2002).  The plasmids would be conjugated into AhD14, a ∆exeD A. hydrophila strain and 
the complementation test would be performed to assess the effect of the two-codon insertion 
mutants on secretion assembly. 
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6. Concluding Remarks 
The most striking result obtained in this study is the evidence for interactions between ExeA/B 
and ExeD.  Previous studies have revealed that the ExeAB complex is required for the 
assembly and/or multimerization of the ExeD secretin in the OM, possibly using energy derived 
from ATP hydrolysis.  In this study, the yeast two-hybrid assay was used to demonstrate 
interactions of ExeA/D and ExeB/D, suggesting that the ExeAB complex plays a direct role in 
the transport of ExeD into the OM.  However, it is not clear if the association of the ExeAB 
complex and ExeD homododecamer occurs during or after transport/assembly.  Furthermore, it 
has been suggested that the pilotin GspS, a component of the OM complex, is required to 
protect secretins from proteolysis and to direct its insertion to the OM (Hardie et al, 1996a, b; 
Daefler and Russel, 1998; Shevchik and Condemine, 1998; Guilvout et al., 2006), suggesting 
that ExeA and ExeB are analogs of GspS which play a similar role in A. hydrophila.  However, 
the Out system of E. chrysanthemi contains OutB and OutS while no GspA homologue has 
been found, and both OutS and OutB are apparently involved in the stability and OM 
localization of OutD.  It is not clear whether they perform overlapping, the same or separate 
functions.  Another general OM insertion factor Omp85 (YaeT) in N. meningitides has also 
been proposed to be involved in secretin assembly (Voulhoux et al, 2003; Bayan et al, 2006).  
However, Collin t al. (2007) suggested that multimerization and OM association of PulD was 
YaeT-independent.  It is possible that the GspA, GspB, GspS and Omp85 (YaeT) carry out 
similar or overlapping functions in the localization and assembly of GspD, with various 
combinations of these factors acting in different systems for the successful assembly of the 
secretin.  In addition to the interaction between ExeA/ExeB and ExeD, the interaction between 
ExeC and ExeD in the periplasm was confirmed by the yeast two-hybrid assay of this study, 
corresponding to the previous results showing that the C-terminal peri-GspC is involved in an 
interaction with GspD (Robert et al., 2005a; Korotkov et al., 2006).   
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